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ABSTRACT
A mutation in the DYT1 gene on chromosome 9q34 is the commonest cause 
of young-onset primary dystonia. The penetrance of clinical symptoms is low 
(only 30-40% of gene carriers manifest dystonia), and occurs in an age- 
dependent fashion. Mutation carriers who pass their mid-twenties without 
developing symptoms almost invariably stay symptom free for life. DYT1 
mutation carriers therefore provide a unique model with which to study brain 
function in primary dystonia, and factors that may protect against 
development of clinical symptoms in those who are genetically susceptible.
This thesis describes the use of electrophysiological techniques to determine 
1) if manifesting DYT1 carriers have similar deficits in motor function to non- 
genetic primary dystonia, and 2) what are the consequences of the DYT1 
mutation for motor system physiology in non-manifesting carriers.
We found abnormalities of inhibitory motor circuits at cortical and spinal cord 
levels in manifesting DYT1 subjects. Surprisingly, we found cortical motor 
abnormalities of a similar nature and severity in non-manifesting DYT1 
carriers, despite their lack of symptoms.
We subsequently demonstrated abnormal reciprocal inhibition in manifesting 
DYT1 subjects was partially normalised by 1Hz repetitive transcranial 
magnetic stimulation (rTMS), but that this same stimulus had no effect on
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non-manifesting DYT1 subjects or controls. We explored motor system 
plasticity further in a separate experiment, using a new method of rTMS 
(theta burst stimulation) as an experimental "plastic force". We found an 
excessive response to rTMS in manifesting DYT1 subjects and subjects with 
adult-onset dystonia (torticollis). In contrast we found a sub-normal response 
to rTMS in non-manifesting DYT1 subjects.
These data suggest that the DYT1 mutation causes abnormalities in cortical 
motor inhibitory function in all gene carriers, regardless of symptoms, but that 
a differential sensitivity of the system that underlies synaptic plasticity plays a 
primary role in determining whether mutation carriers will develop clinical 
dystonia.
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Thesis Overview
Chapter 1 will introduce the topic of dystonia from an historical perspective 
and cover advances in classification of dystonia from an anatomical, 
aetiological and genetic point of view. DYT1 dystonia will be introduced, and 
shown to provide a useful model with which to investigate the 
pathophysiology of dystonia. Hypotheses that were generated with respect to 
DYT1 mutation carriers are presented.
Chapter 2 provides a literature review regarding the pathophysiology of 
primary dystonia in general, and also the specific case of DYT1 mutation 
carriers. This chapter will also explore the concept of brain plasticity, how this 
can be studied experimentally, and how abnormalities in the regulation of 
brain plasticity might be relavent to the pathophysiology of dystonia.
Chapter 3 presents the methods used in the experiments described in the 
thesis.
Chapter 4 presents details of clinical data obtained during patient 
ascertainment for this study, focussing on unusal phenotypes in DYT1 
mutation carriers, and providing a review of the clinical features of previously 
published cases with the DYT1 mutation.
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Chapter 5 describes the first set of experiments where eiectrophysiological 
assessments of cortical and spinal motor function were performed in 
manifesting and non-manifesting DYT1 mutation carriers.
Chapter 6 presents the details of an experiment looking at modulation of 
spinal reciprocal inhibition using repetitive transcranial magnetic stimulation 
as an experimental "plastic force" in manifesting and non-manifesting DYT1 
mutation carriers and controls.
Chapter 7 presents the details of an experiment to assess cortical motor 
system plasticity in manifesting and non-manifesting DYT1 gene carriers, 
subjects with adult-onset dystonia (torticollis) and controls.
Chapter 8 summarises the results of all the experiments and uses them to 
generate hypotheses that explain the penetrance of clinical symptoms in 
DYT1 carriers. The data are placed in the context of current knowledge 
regarding the pathophysiology of primary dystonia in general, and specifically 
those with dystonia due to the DYT1 mutation. Suggestions are made 
regarding potential clinical applications of the results from the current 
research, and the direction which future work could take.
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Chapter 1
Introduction to the concept of dystonia and generation of initial 
hypotheses.
The concept of dystonia has a somewhat chequered history, plagued from the 
very beginning by implications of a psychogenic rather than organic origin. 
This is reflected in the one of the first descriptions of dystonia in three siblings 
with young-onset dystonia. They were described by Schwalbe in 1908 as 
"familial cramps with hysterical features"(Truong and Fahn, 1988). The term 
dystonia was coined by Oppenheim in 1911 when he described two patients, 
one with "dysbasia lordotica progressiva" and the other with "dystonia 
musculorum deformans". These terms were selected, it appears, depending 
on the site and functions affected (abnormal gait with twisted postures in the 
first patient and abnormal muscle spasms and postures of the limbs in the 
second). Subsequently, the term dystonia came to be used for patients with 
abnormal postures, particularly for mobile abnormalities rather than fixed 
postures.
Definition and classification of dystonia
The current commonest definition of dystonia, produced by the Scientific 
Advisory Board of the Dystonia Medical Research Foundation, is that dystonia 
is "a syndrome of sustained muscle contraction, frequently causing twisting
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and repetitive movements or abnormal postures."(Fahn and Eldridge, 1976). 
The initial classification system of patients with dystonia was an anatomical 
one, and, somewhat surprisingly perhaps, this system still has notable clinical 
relevance. Patients can be classified as focal (one body part only affected), 
segmental (two contiguous body parts affected), multifocal (two or more non­
contiguous body parts affected), hemidystonia (one side of the body 
affected), or generalised dystonia (two or more contiguous body parts 
affected plus trunk) (Fahn and Eldridge, 1976). Other terms are used to 
describe the anatomical distribution of the dystonia, and also, in some cases, 
are used as a diagnostic label. These terms include: blepharospasm (dystonia 
affecting orbicularis oculi), oromandibular dystonia, laryngeal dystonia, 
torticollis (a general term for dystonia affecting the neck, as well as a specific 
description of head turning caused by dystonia, differentiating it from a head 
tilt to the side (laterocollis), forward (anterocollis) or back (retrocollis)), 
writer's cramp (task-specific dystonia affecting the action of writing, but not 
other tasks.)
When this anatomical system of classification is applied to patients with 
dystonia, patterns of anatomical involvement that relate to age at onset are 
revealed. Most important of these is that dystonia with childhood or teenage 
onset is typically the generalised form, whereas adult-onset dystonia is 
typically focal (Fahn and Eldridge, 1976). In addition, there appears to be a 
somatotopic "gradient" of dystonia related to age at onset. Dystonia affecting 
the feet or legs is only usually seen in those with young-onset primary
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dystonia, and even though generalisation of symptoms is typical, involvement 
of cranio-cervical structures is unusual (Bressman et al., 1998; Bressman et 
al., 2000). Task-specific dystonias, in particular writer's cramp, tend to have 
an age at onset of about 30-40 years of age (Jedynak et al., 2001). Cervical 
dystonia tends to have a later age at onset of about 40-50 years of age 
(Jahanshahi et al., 1990), with blepharospasm having the latest average age 
at onset at about 50-60 years of age (Jankovic and Orman, 1984). There is 
therefore a rostral-caudal gradient of involvement by dystonia that depends 
on age at onset (Bressman, 2004; Bressman et al., 1994). There are also sex 
differences in the anatomical distribution of dystonia in that task-specific limb 
dystonias are commoner in men (Cohen and Hallett, 1988), whereas cranio- 
cervical dystonias are commoner in women (Jahanshahi e t al., 1990; Jankovic 
and Orman, 1984).
A more recent classification system of dystonia is an aetiological one. In this 
system, the main separation is between dystonic syndromes that are 
"primary" and those that are "secondary/heredodegenerative"(Fahn and 
Eldridge, 1976). In primary dystonia, dystonia is the only clinical feature (+ /- 
tremor), and no structural or neurodegenerative cause is present. Patients 
with secondary dystonia may have other clinical features apart from dystonia, 
and a structural or environmental cause is present. In heredodegenerative 
dystonia, dystonia is typically just part of a wider neurological syndrome 
which is progressive, and often includes dementia. It should be noted that the 
diagnosis of primary dystonia does not equate to a diagnosis of "idiopathic"
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dystonia: genetic diagnosis of primary dystonia, particularly the young-onset 
variety, is possible in some cases.
Other groups in this aetiological classification include paroxysmal dystonias, 
psychogenic dystonia and "dystonia plus" syndromes. These "dystonia plus 
syndromes" are conditions where dystonia occurs together with other 
movement disorders, but where there is no secondary or neurodegenerative 
cause (Bressman, 2004). Only two conditions are included under this heading: 
dopa-responsive dystonia (DRD) and myoclonic dystonia. In DRD (Segawa 
syndrome) there is an underlying deficit in the gene encoding guanidine 
triphosphate cyclohydrolase 1 (GTPCH1), which is a rate limiting step in the 
metabolism of tetrahydrobiopterin, itself an essential co-factor in the 
production of dopamine from tyrosine (Ichinose et al., 1994; Ichinose et al., 
2001). These patients typically have young-onset limb dystonia with in many 
cases parkinsonism and mild pyramidal signs. A diurnal fluctuation of 
symptoms is reported in a proportion of patients with worsening of symptoms 
throughout the day(Bandmann et al., 1998). Phenotypic variability is 
common, but in almost all cases a dramatic and sustained response to 
levodopa is seen.
In myoclonic dystonia, familial early childhood onset dystonia (typically 
affecting the neck and arms) is accompanied by myoclonus in a similar 
distribution (Quinn, 1996). The myoclonic jerks are described as "lightning 
jerks", and alcohol responsiveness is common (Quinn, 1996). Recently,
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mutations in the epsilon sarcoglycan gene (SGCE) have been found in a 
proportion of patients with myoclonic dystonia (Zimprich et al., 2001). The 
gene shows maternal imprinting, so that offspring receiving a mutant gene 
from their mother will almost never show symptoms, in contrast to those who 
receive a mutant gene from their father, where penetrance is almost 
complete (Grabowski e t al., 2003). A summary of ways of classifying dystonia 
are given in table 1.1.
Table 1.1: Different wavs of classifying dvstonia
By age at onset By distribution By aetiology
Young-onset dystonia Focal Primary (dystonia only +/-
(< 28 years)
Segmental
tremor; no neurodegeneration.
Adult-onset dystonia (> Dystonia-plus syndromes
28 years) Multifocal - Dopa-responsive 
dystonia
Hemidystonia Myoclonus dystonia
Generalised Secondary
Symptomatic 
- Heredodegenerative
Paroxysmal
Familial forms of dystonia have been recognised for many years, and genetic 
investigation of such families have revealed a number of possible loci and in 
some cases particular gene mutations relating to certain types of dystonia.
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These are largely summarised In the "DYT" gene classification system, which 
currently extends from DYT1 to 15 (Nemeth, 2002).
Table 1.2 gives a outline of the conditions covered in the DYT system. Many 
different aetiological types of dystonia are covered in this classification system 
(primary, paroxysmal, dystonia-plus, heredodegenerative). Only four genes 
have actually been identified in these conditions, and currently, commercial 
testing is only widely available for one of these: DYT1. Some DYT numbers 
are based on clinical description only (e.g. DYT2 (Gimenez-Roldan et al.,
1988; Gimenez-Roldan e t al., 1976)), and are not even accompanied by 
linkage to a particular region. For all these reasons the DYT classification can 
appear muddled and clinically unhelpful. In its current form, the DYT 
classification system is simply a list of some (but by no means all) of the 
genes/loci that have been identified as causing dystonic syndromes, and over 
and above this, it has little functionality.
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Table 1.2: The DYT Classification of Pvstonia
DYT
Number/name 
of condition
Age at 
onset
Clinical
Features
Inheritance Gene Gene
testing
available?
DYT1
Oppenheim’s
dystonia,
idiopathic
torsion
dystonia
Before 25 
yrs
Young-onset
primary
generalised
dystonia
AD with 
low
penetrance
GAG deletion in 
DYT1 gene
Service
testing
available
DYT2 ? Autosomal 
recessive 
young-onset 
generalised 
dystonia 
described in 
Spanish gypsy 
family
AR Unknown No
DYT3
X-linked
dystonia
parkinsonism,
Lubag
Adult Progressive
dystonia
parkinsonism
predominantly
in Filipino
males
X-linked
recessive
(some
females
affected)
TAF1 Possibly on 
a research 
basis
DYT4
Whispering
dysphonia
13-37 Laryngeal 
dystonia in an 
Australian 
family. 
Torticollis + 
generalised 
dystonia seen
AD Unknown No
DYT5
Dopa-
responsive
dystonia,
Segawa’s
disease
Childhood Young-onset 
dystonia 
parkinsonism 
with diurnal 
variation and 
response to 
levodopa
AD GTPCH1 gene 
(Tyrosine 
hydroxylase 
deficiency causes 
a similar, but more 
severe phenotype)
Yes
DYT6 Variable:
average
19yrs
2 Mennonite 
families with 
limb and 
cranio- 
cervical 
dystonia
AD Linkage to 8p21-
p22
No
DYT7 28-70yrs German 
family with 
focal
craniocervical
dystonia
AD Linkage to 18p No
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DYT
Number/name 
of condition
Age at 
onset
Clinical
Features
Inheritance Gene Gene
testing
available?
DYT8
Paroxysmal
non-
kinesogenic
choreoathetosis
Childhood-
teenage
years.
Attacks of
dystonia and
chorea
precipitated
by alcohol,
coffee,
fatigue.
AD Myofibrillogenesis 
regulator 2 gene
Possibly on 
a research 
basis
DYT9 Childhood,
teenage
years
Episodic 
chorea and 
ataxia with 
progressive 
interictal 
spasticity
AD Linkage to lp No
DYT 10 
Paroxysmal 
kinesogenic 
choreoathetosis
Childhood-
teenage
years
Brief attacks 
of chorea and 
dystonia 
precipitated 
by sudden 
movement
AD Linkage to 
pericentromeric 
region of 
chromosome 16 in 
some families
No
DYT 11
Myoclonus
dystonia
Childhood Myoclonus 
+/- dystonia 
responsive to 
alcohol
AD with 
maternal 
imprinting
Epsilon
sarcoglycan gene
Yes
DYT 12 
Rapid-onset 
dystonia 
parkinsonism
Variable Dystonia and 
parkinsonism 
developing 
over
hours/days,
often
following
infection
AD ATP 1 A3 gene 
mutations
Possibly on 
a research 
basis
DYT 13 Childhood-
adult
Cranio- 
cervical 
dystonia in 
one Italian 
family
AD Linkage to 
lp36.13-36.32
No
DYT 14 
Dopa- 
responsive 
dystonia
Single 
case: onset 
age 3
Dopa-
responsive
dystonia
parkinsonism
? Linkage to 
chromosome 
14q 13, but outside 
region of 
GTPCH1 gene
No
DYT 15 Childhood-
adult
Myoclonus 
+/- dystonia 
responsive to 
alcohol
AD Linkage to 18pl 1 No
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DYT1 dystonia -  from primary torsion dystonia to the DYT1 gene
Amongst familial forms of primary dystonia, the most common pattern is of 
young-onset (late childhood/early teens) dystonia, starting in a limb and then 
becoming generalised, but usually sparing the cranio-cervical region. This 
pattern has been recognised for many years and became known as primary or 
idiopathic torsion dystonia (Fahn and Eldridge, 1976). Since the delineation of 
this clinical phenotype it was recognised to have a high prevalence amongst 
the Ashkenazi Jewish population (Bressman et al., 1994), and it was a source 
of dispute whether this was even the same condition as that which occurred 
amongst non-Jewish people (Burke et al., 1986). The mode of inheritance 
was also a source of debate -  a recessive inheritance was most often 
favoured, although dominant inheritance with reduced penetrance was also 
suggested (Bressman et al., 1988).
Linkage studies in a large number of Ashkenazi Jewish families identified a 
candidate region on chromosome 9q34, and also confirmed the inheritance to 
be autosomal dominant with low penetrance of approximately 30%(Bressman 
et al., 1994). The increased prevalence in the Ashkenazi Jewish population is 
thought to be due to a "founder effect", i.e. a population bottleneck that 
occurred in the past. The origins of the founder effect in respect to the DYT1 
mutation have been traced back to the 1600s, where pogroms against the 
Jewish community in Eastern Europe created a small population in which 
interbreeding occurred (Risch et al., 1995). Later, non-Jewish families with
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the idiopathic torsion dystonia phenotype were linked to the same region of 
chromosome 9, and in 1997 the responsible mutation was identified in the 
DYT1 gene (also known initially as the TOR1A gene) (Ozelius et al., 1997). 
This mutation is a single GAG deletion that removes a glutamate residue from 
close to the ATP binding end of the protein torsin A (Ozelius et al., 1997).
The DYT1 phenotype
The phenotype associated with this mutation was initially thought to be 
simply that of typical idiopathic torsion dystonia with childhood limb-onset 
dystonia that generalises in most cases and then stops progressing, with 
cranio-cervical involvement not seen. As DYT1 testing became more 
widespread, a significant phenotypic variability became apparent. The 
variability of this phenotype is analysed in detail in the clinical study described 
in chapter 3.
The issue of penetrance of clinical symptoms in DYT1 gene carriers.
A feature of the DYT1 mutation that is critical to the design of the studies 
presented here is that of its low age-dependent penetrance. Penetrance of 
clinical symptoms in DYT1 mutation carriers is approximately 30%, and 
almost all those who are going to manifest symptoms will do so before the 
age of 25. DYT1 mutation carriers therefore present a unique opportunity to 
the researcher with an interest in the pathophysiology of dystonia. Firstly, in
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contrast to many other genetic forms of dystonia, the mutation is relatively 
common, and therefore it is feasible to collect a cohort of a reasonable size in 
whom to conduct experiments. Secondly, in contrast to other patients with 
primary dystonia, patients with dystonia due to the DYT1 mutation have a 
common underlying cause despite variable severity of symptoms, and this 
helps to eliminate possible bias in experiments from a lack of homogeneity of 
subjects in terms of underlying aetiology. Thirdly, penetrance is low, providing 
a cohort of individuals who carry the DYT1 mutation, but who do not manifest 
symptoms. Due to the known age-dependency of manifestation of symptoms, 
the researcher can be reasonably confident that non-manifesting gene 
carriers over the age of thirty will not manifest symptoms in the future and 
thus can be considered as truly different from manifesting gene carriers 
(Bressman et al., 2000).
Aims and Hypotheses
We had two main aims. Our first aim was to use electrophysiological 
techniques to probe the function of the motor system in manifesting DYT1 
carriers. For the reasons outlined above, this group of patients are of interest 
with regard to understanding the pathophysiology of primary dystonia, and 
have not previously been studied electrophysiologically. Our second aim was 
to use the unique natural model provided by the low, age-dependent 
penetrance of DYT1 dystonia to try to understand the mechanisms that drive 
the development of clinical symptoms in genetically susceptible individuals
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We set out to test four main hypotheses in these initial experiments:
1. That manifesting gene carriers would have similar abnormalities in cortical 
and spinal motor inhibitory function as previously described in non-genetically 
characterised primary dystonia.
2. That non-manifesting gene carriers are asymptomatic as the DYT1 
mutation has no consequences for them (perhaps as it is inactivated by some 
mechanism).
3. That electrophysiological abnormalities are present in non-manifesting gene 
carriers that affect similar systems to those seen in manifesting gene carriers, 
but are of a lesser severity, and do not reach the threshold for clinical 
symptoms to be produced.
4. That non-manifesting gene carriers have only a sub-set of the 
pathophysiological abnormalities present in manifesting gene carriers, and 
these are not sufficient to produce clinical symptoms.
Based upon data from the experiments described in chapter 4, further 
hypotheses were generated leading to experiments described in chapters 5 
and 6:
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1. That carriers of the DYT1 mutation who develop dystonia will have an 
excessive response to an experimental plastic force.
2. That subjects with adult-onset non genetically characterised dystonia 
(torticollis) will have an excessive response to an experimental plastic 
force.
3. That carriers of the DYT1 mutation who do not develop dystonia will 
have a sub-normal response to an experimental plastic force.
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Chapter 2
The Pathophysiology of Primary Dystonia
The development of the clinical concept of dystonia outlined in the last 
chapter was paralleled by a developing understanding of the underlying 
pathophysiology of dystonia in general and primary dystonia in particular. As 
the clinical concept of dystonia has moved from anatomy to aetiology to 
genetics, so has the pathophysiological understanding. The last step has been 
particularly fuelled by the discovery of the DYT1 gene mutation. This has 
opened an entirely new field of study in dystonia research: the function of 
torsin A and its role a t a molecular level within the cell. It is likely that this 
work will lead to better understanding of primary dystonia in general.
The basal ganglia and dystonia
Simply at a conceptual level, dystonia, as a movement disorder, was thought 
to arise from dysfunction within the basal ganglia. Indeed, the observation 
that dystonia could occur secondary to lesions of the basal ganglia (Bhatia 
and Marsden, 1994) strengthened the view that in primary dystonic conditions 
(where no basal ganglia damage was seen) there was likely to be a functional 
disturbance of basal ganglia modulation of cortical motor pathways.
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Cortical function in dystonia
A variety of techniques have been employed to study the function of the 
motor system at a cortical level in primary dystonia.
Transcranial magnetic Stimulation (TMS)
Transcranial magnetic stimulation (TMS) is a non-invasive method of 
stimulating cortical neurons. A magnetic field generator drives a current of 
approximately 200ps with a peak amplitude of 8,000 A through an induction 
coil placed on the scalp. The current creates a time-varying magnetic field 
perpendicular to the coil. The magnetic field penetrates the skull and then 
induces an eddy current parallel to the coil in the brain. This current is 
capable of stimulating the brain and can produce descending volleys in the 
corticospinal pathway which can be recorded using surface EMG from the 
appropriate muscles.
A figure of eight coil is often used to provide a more focal stimulus than that 
obtained from a simple circular coil. If a figure of eight coil is held such that 
the TMS pulse causes current to flow in an posterior-anterior direction 
perpendicular to the central sulcus, then this tends to provide the lowest 
threshold for stimulation and appears to activate corticospinal neurons trans- 
synaptically (Di Lazzaro et al., 2001). As stimulation intensity is increased, a 
rising proportion of activation occurs directly.
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The tendency for trans-synaptic activation means that the response to TMS is 
altered by the excitability of these synapses at the time of stimulation. 
Therefore TMS is useful as a technique to explore the integrity and excitability 
of motor pathways, and can be applied before and after an intervention to 
determine whether a change in synaptic excitability has occurred.
In order to understand the literature on TMS techniques applied to patients 
with dystonia outlined below, certain aspects of TMS methodology deserve 
particular comment. First is the concept of the motor "hot spot". This is the 
area on the scalp over with TMS of a particular intensity produces the largest 
motor evoked response (MEP) from the target muscle. Due to ease of 
stimulation, the most commonly used target muscle is the first dorsal 
interosseus (FDI). Surface EMG is recorded from FDI during stimulation, and 
once the "hot spot" has been identified it is marked on the scalp. Second is 
the concept of resting and active motor thresholds. Resting motor threshold 
(RMT) is the intensity of stimulation that produces no detectable EMG 
response from the target muscle when that muscle is relaxed. Active motor 
threshold (AMT) can be defined as the intensity of stimulation that produces 
an EMG response of less than 200pV in less than five out of ten trials when 
the target muscle is voluntarily contracted. Typically feedback is given to the 
subject to maintain this voluntary contraction at a set level (about 20-30% of 
maximal contraction).
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A variety of TMS methodologies have been applied to patients with dystonia 
and have provided important insights into dystonia pathophysiology.
Input/Output curves
Although no differences have been found in thresholds for activation of 
muscles in dystonia subjects compared to controls, differences have been 
observed in the input/output relationship in response to TMS. In these 
experiments, the RMT for a particular individual is established, and then TMS 
pulses at increasing intensity of stimulation based on percentages of RMT are 
delivered, and the size of the resulting MEP recorded. This provides an 
input/output curve where MEP size is plotted against magnitude of TMS 
intensity. In dystonic subjects, a significantly enhanced input/output curve is 
found, such that MEP size is significantly larger for a given input compared to 
control subjects (Ikoma et al., 1996; Mavroudakis et al., 1995). This finding 
has been interpreted as demonstrating increased motor system excitability in 
dystonia. A difficulty with this interpretation (and one that interferes with the 
interpretation of many experiments in those with dystonia) is that muscle 
activity directly influences the size of MEP produced from TMS of a given 
intensity of stimulation. Muscle activation (or even thinking about muscle 
activation) increases MEP size. This means that scrupulous monitoring of 
baseline EMG in the target muscle (and perhaps ideally the adjacent muscles 
too) is required in order to prevent this possible artefact in experiments in
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dystonic subjects, who may have a significant amount of involuntary muscle 
activity.
Short Intracortical inhibition and facilitation.
Kujirai e t al (Kujirai e t al., 1993) developed a paired pulse TMS technique 
which is thought to stimulate different populations of inhibitory and excitatory 
interneurons, and provides measures of their excitability: intracortical 
inhibition and facilitation. The standard method explores the influence of a 
sub-threshold "conditioning" pulse on the size of the MEP produced by a 
subsequent "test" pulse. The intensity of the test pulse is usually set to 
achieve an MEP of about lmV when given alone. The conditioning pulse is 
then given at different time intervals prior to the test pulse.
In studies with normal subjects, the conditioning pulse given l-5m s prior to 
the test pulse causes a reduction in the resulting MEP (Kujirai et al., 1993). 
This effect is known as short interval intracortical inhibition (SICI). The effect 
is enhanced by GABAa agonists, NMDA receptor blockers and dopamine 
agonists and is blocked by dopamine antagonists (Ziemann et al., 1996a; 
Ziemann et al., 1996b; Ziemann et al., 1996c). It is proposed that SICI is a 
GABAa mediated pathway that has an inhibitory influence of corticospinal 
tract excitability.
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There is a cross-over or intermediate period of response when the 
conditioning pulse is given between 6 and 9ms prior to the test pulse, where 
little effect is seen on the resulting MEP. At interstimulus intervals (ISI) of 10- 
20ms an increase in the size of MEP is typically seen, a phenomenon known 
as intracortical facilitation (Kujirai et al., 1993). The mechanism of this effect 
is unclear at the present time. It can be modified by rTMS independently of 
SICI indicating that different pathways underlie the two phenomena 
(Peinemann et al., 2000). Currently it is thought most likely to be a glutamate 
mediated event (Ziemann et al., 1996c).
SICI can be influenced by the intensity of the conditioning pulse. SICI is 
recordable using conditioning pulse intensity of 60% RMT at and ISI of 3ms. 
The magnitude of the effect increases as the intensity of the conditioning 
pulse is increased, and reaches a maximum at approximately 90% of RMT or 
80% AMT(Kujirai et al., 1993; Ziemann e t al., 1996d). Further increases in 
intensity lead to progressively less SICI. Although less certain, it may be that 
the optimum intensity for producing ICF is slightly higher than that for SICI.
There have been a number of studies exploring SICI and ICF in patients with 
primary dystonia (Berardelli e t al., 1998b). The most consistent finding has 
been of a reduction in SICI in dystonic individuals (Ridding et al., 1995). This 
has been interpreted as a failure of inhibitory control of motor pathways, 
which could lead to problems in focusing desired movement and could lead to 
unwanted muscle activity (Berardelli e t al., 1998b). As with input-output
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experiments, measurement of SICI (and ICF) is hampered by muscle 
contraction -  it will tend to reduce SICI and increase ICF. However, 
reductions in SICI have been demonstrated using target muscles that are not 
involved by dystonia (e.g. FDI in patients with cervical dystonia). However, 
the question remains as to the effect on SICI and ICF of even distant 
involuntary muscle activity. Abnormalities in ICF have been more variable, but 
some studies have reported increases in ICF (Sommer et al., 2002a), again in 
keeping with an over-excitable corticospinal system.
Silent period
The silent period is a period of EMG silence that occurs following a TMS shock 
delivered over representative area of cortex of a voluntarily contracting 
muscle. Typically, constant sub-maximal contraction of FDI is achieved via the 
use of auditory or visual feedback. A TMS pulse is then delivered over the 
motor hotspot relating to the FDI at an intensity of 110-130% of RMT (with a 
higher stimulus intensity possibly providing a more consistent result (Orth and 
Rothwell, 2004)). A temporary break in EMG activity will occur which is called 
the silent period. This can be measured in a variety of ways, but perhaps 
most reliably by measuring the interval between the onset of the stimulus 
artefact and the first recovery of EMG activity.
Studies in normal subjects typically find the silent period to be 100-120ms in 
length. Via examining the effect of GABAa and GABAb antagonists and
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agonists, Ziemann et al have proposed that the SP is a GABAb mediated 
process (Ziemann et al., 1996c). There is likely to be a small additional spinal 
component (Inghilleri et al., 1993).
In dystonic subjects a number of studies have found a shortened silent period 
(Berardelli e t al., 1998b). This would suggest a deficit in GABAb mediated 
inhibition in dystonia.
Pre-movement potentials
Two types of pre-movement potential have been recorded in dystonia: the 
Bereitschaftspotential (BP) and the contingent negative variation (CNV). The 
BP is a slow rising (negative) EEG potential that begins 1.5-2 seconds prior to 
a self-paced voluntary movement. Initially the potential is diffuse and bilateral 
(NS1: bilateral primary and supplementary motor area activity), and then 
becomes lateralised (NS2: contralateral primary motor area activity). The CNV 
is recorded in a different fashion. Here EEG is recorded between a warning 
cue and a "go" signal to perform a particular movement. During the gap 
between the two stimuli, a slow negative potential is recorded which, like the 
BP, is at first bilateral and then lateralises to the representative hemisphere 
for the planned movement.
Studies of the BP and CNV in patients with primary dystonia have found a 
reduction in amplitude of the potentials compared to normal subjects. In most
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experiments this abnormality was only present when the planned movement 
involved a body part affected by dystonia (Deuschl et al., 1995; Ikeda et al., 
1996; Van der Kamp et al., 1995).
Brainstem motor function in dystonia.
Blink reflexes
At a brainstem level, the most studied circuit is the blink reflex and in 
particular the blink reflex recovery cycle.
If a stimulus is delivered to the supraorbital nerve of sufficient intensity, an 
ipsilateral contraction of orbicularis oculi will occur (R1 component) followed 
by a bilateral contraction of orbicularis oculi (R2 component).
The blink reflex recovery cycle is typically assessed by delivering paired 
stimuli to the supraorbital nerve a different interstimulus intervals, and 
comparing the size of the R2 response to that obtained when a single 
stimulus is given. In normal subjects interstimulus intervals of less than 
750ms typically result in a significantly reduced R2 size. In certain types of 
dystonia (blepharospasm, cervical dystonia, generalised dystonia) this 
recovery cycle is enhanced such that the R2 component is large even at ISIs 
of 250-500ms (Berardelli et al., 1985; Eekhof et al., 1996; Nakashima et al., 
1990; Tolosa et al., 1988). Although abnormalities of the blink reflex recovery
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cycle are clearly seen in some types of dystonia that clinically do not involve 
orbicularis oculi, some studies have failed to find blink reflex recovery cycle 
abnormalities in other types of dystonia such as segmental dystonia not 
involving the head or neck(Nakashima et al., 1990).
Other brainstem abnormalities.
The masseteric inhibitiory reflex is obtained by stimulating the masseteric 
nerve during voluntary muscle contraction. This masseteric silent period has 
two phases (SP1: early; SP2: late) and in normal subjects has a recovery 
period such that the second of two paired stimuli of short ISI will fail to cause 
an SP2 response. As with the blink reflex, studies in dystonia have found that 
this reflex recovery cycle is more excitable than normal subjects. This is true 
of patients with oromandibular dystonia as well as those without any clinical 
dystonic involvement of jaw muscles(Pauletti et al., 1993).
Vestibular abnormalities have been reported in those with torticollis, although 
it is not clear if these are primary to the dystonia or are secondary to a 
prolonged period of abnormal head position. The latter seems most likely as 
in general studies have found a suppression of normal vestibular responses 
(Bronstein and Rudge, 1988).
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Spinal motor abnormalities in dystonia
Although primary dystonia by definition does not present clinically with signs 
of corticospinal or radicular dysfunction, electrophysiological testing has 
revealed deficits in spinal reflex control.
The H reflex (described by Hoffman in 1918) is effectively an electrical 
method of mimicking the tendon tap reflex, although one which bypasses the 
muscle spindle as the afferent nerve fibres are stimulated directly. Although 
the H reflex has been obtained from a variety of muscles, flexor carpi radialis 
and soleus are in general the most reliable.
The H reflex in those with dystonia has been found to have a shorter recovery 
cycle compared to normal subjects when stimuli are given with ISI of 200ms. 
This finding is not just the case for those with dystonia involving the limb 
assessed, but also in those with craniocervical dystonia, without clinical 
involvement of the limbs.
Reciprocal inhibition is a technique that explores experimentally the issue of 
interaction between agonist and antagonist muscles: an issue of central 
importance to the pathophysiology of dystonia. Reciprocal inhibition (RI) 
assesses the interaction between stimulation of the radial nerve supplying the 
extensor muscles of the forearm and the H reflex produced by stimulation of 
the median nerve. At particular interstimulus intervals (ISIs), a reduction in
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the size of the H reflex occurs in normal subjects (Day et al., 1984). The first 
phase of inhibition, occuring at ISIs of approximately 0msec, is mediated by a 
glycinergic disynaptic inhibitory pathway (Day et al., 1984). The second phase 
of inhibition, occuring at ISIs of 10-20msec, is thought to be due to 
presynapic la inhibition of afferent fibres that mediate the H reflex (Berardelli 
et al., 1999). The origin of the third phase of inhibition, occurring at ISIs of 
70-500msec, is less well known and might go through the polysynaptic long 
latency stretch reflex pathway (Chang et al., 1997).
Studies in those with dystonia (both with dystonic involvement of the tested 
limb or without) have found a reduction of inhibition that occurs at the 2nd 
and 3rd phases.
Kinematic studies in dystonia have demonstrated overlapping activity of 
agonist and antagonist muscles and a slowness (but not fatiguing) or 
movement. The normal triphasic pattern of agonist and antagonist activity 
appears to be lost, and movements are characterised by a high degree of 
variability (van der Kamp et al., 1989).
Sensory system abnormalities in dystonia
The presence of the "sensory geste" in those with dystonia has long been 
viewed as a pointer to a possible role for abnormal sensory function in 
dystonia.
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Early studies found inconsistent abnormalities in the late (N30) component of 
the somatosensory evoked potential (Onofrj et al., 1995; Reilly et al., 1992). 
Certainly, modification of sensory input can affect dystonia symptoms.
Afferent blockade by local anaesthetic can reduce the severity of dystonic 
symptoms (Yoshida et al., 2002). There is an abnormal response to vibration 
of the affected and unaffected body parts of those with dystonia (Yoneda et 
al., 2000).
In an elegant study, Tinnazi and colleagues examined the amplitude of the 
N20 component of the SEP obtained in normal and dystonic subjects when 
the median or ulnar nerve were stimulated separately, or when both were 
stimulated together (Tinazzi e t al., 2000). They hypothesised that in normal 
subjects the N20 from the paired SEP would be smaller than the arithmetical 
sum of the N20 derived from unpaired stimulus of the median and ulnar nerve 
due to sensory "gating", a phenomenon thought to help the integration of 
sensory input in the brain.
This "gating" of sensory input was indeed found in normal subjects, but in 
those with dystonia, the N20 from paired stimuli was much greater than 
normal subjects, and close to the arithmetical sum of the single stimuli. This 
would suggest that the sensory system in dystonia fails to integrate complex 
sensory information.
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Transcranial magnetic stimulation has been used to study sensorimotor 
integration in dystonia (Abbruzzese, 2001). In this study 12 patients with 
focal hand dystonia were compared with 16 normal subjects. All subjects 
received electrical stimulation of the median nerve at intervals of 50, 200, 600 
or 1000ms prior to a TMS shock delivered over the hand motor area 
correcponding to abductor policis brevis. In normal subjects an inhibitory 
effect of median nerve stimulation was seen on MEP, maximal at an ISI of 
200ms. In contrast, subjects with focal hand dystonia showed no such 
inhibition of MEP size, and indeed demonstrated facilitation instead. This 
study demonstrates abnormal interaction between sensory input and motor 
output in dystonia.
Imaging in dystonia
Structural imaging
Simple structural imaging is normal in primary dystonia. High field studies in 
dystonia (spasmodic torticollis) have identified prolonged T2 relaxation times 
in the lentiform nucleus compared to normal subjects (Schneider et al., 1994).
More recently, voxel-based morphometry has been used to look at brain 
anatomy in dystonia. In one study of 10 patients with torticollis (Draganski et 
al., 2003), voxel-based morphometry revealed an increase in gray matter 
density bilaterally in the motor cortex and in the cerebellar flocculus and
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unilaterally in the right globus pallidus internus. In addition, a decrease in 
gray matter density was observed in the right caudal supplementary motor 
area as well as in the right dorsal lateral prefrontal and visual cortex.
A more recent study of 36 patients with focal hand dystonia, again using 
voxel-based morphometry, revealed significant bilateral increase in gray 
matter in the hand representation area of primary somatosensory and, to a 
lesser extent, primary motor cortices. The finding of bilateral abnormalities in 
those with unilateral dystonia led the authors to suggest that these 
abnormalities might to some extent be primary (Garraux et al., 2004).
Functional imaging
Studies of regional blood flow in dystonia have, in general, found no 
differences compared to normal subjects. There have been suggestions of 
differential glucose metabolism in those with dystonia, and in particular for 
putaminal hypermetabolism, but results are inconsistent (Berardelli et al., 
1998b).
Regional blood flow changes have been examined during movement. 
Ceballos-Baumann and colleagues examined regional blood flow in normal 
and dystonic patients during paced freely selected movements of a joystick 
and during writing. There was underactivity in primary and supplementary
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motor areas, and excessive activation of prefrontal, cerebellar, insula and 
parietal cortex (Ceballos-Baumann and Brooks, 1998).
A study in seven patients with focal arm dystonia using magnetic resonance 
spectroscopy found a reduction of GABA in the sensorimotor cortex and 
lentiform nucleus contralateral to the affected hand, but no such change on 
the ipsilateral side (Levy and Hallett, 2002).
DYT1 dystonia: pathophysiology
Molecular studies
Torsin A is a protein whose function is still not known. It is widely expressed 
throughout the body, and indeed has its highest levels in the liver. However, 
DYT1 dystonia is the only known disease to arise from defects in the DYT1 
gene, and those with DYT1 dystonia have not been found to have o ther  
organs or systems affected directly by the genetic defect.
Within the brain, tors\n  A has a specific localisation. Normal human brains 
have been studied post mortem looking for DYT1 mRNA. The neocortex was 
found to have a largely homogenous low level of DYT1 RNA. There was a 
high level found in the hippocampus, particularly the dentate gyrus and also 
in the substantia nigra pars compacta (specifically in the melanised i.e.
dopaminergic neurons). Little DYT1 mRNA was found within the rest of the 
basal ganglia (Augood e t al., 1999; Konakova et al., 2001).
Torsin A is an ATP-binding protein, and part of the AAA+ family of proteins 
(ATPases Associated with a variety of cellular Activities). This superfamily of 
proteins is highly conserved across species and share an Mg2+-ATP binding 
domain and form a six-membered ring structure (Breakefield e t al., 2001). A 
typical role for these AAA+ proteins is in chaperone function, mediating 
conformational change in other proteins. Other members of the family include 
heat shock proteins (Breakefield et al., 2001).
One role of such proteins that may have relevance for the pathophysiology of 
dystonia is in controlling spatially and temporally membrane fusion processes. 
This may have relevance to later discussion on plasticity in dystonia and DYT1 
where the temporal and spatial control of membrane fusion events between 
neurotransmitter vesicles and the post-synaptic membrane is likely to have 
consequences for the ease in which plastic change can be produced at 
synapses. In this regard, a recent study of cellular localisation of 
overexpressed mutant torsin A is of considerable interest (Misbahuddin et al., 
2005). This study confirmed the localisation of torsin A to the endoplasmic 
reticulum, but in addition identified that the includsions formed by the mutant 
torsin A were immunoreactive for vesicular monoamine transporter 2 
(VMAT2). VMAT2 expression is important for the exocytosis of bioactive 
monoamines in neurons. Abnormal processing, transport, or entrapment of
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VMAT2 within the mutant torsinA membranous inclusions, therefore, may 
affect cellular dopamine release.
Torsin A is an endoplasmic reticulum luminal protein(Hewett et al., 2003), and 
as with other members of the AAA+ family is hypothesised to form a six 
membered ring structure within the lumen of the endoplasmic reticulum. 
Theoretical modelling of the effect of the common DYT1 mutation on this 
structure finds that the mutation could either disrupt closure of the ring, or 
interaction with the partner protein. With equal levels of mutant and wild-type 
protein within the cells, activity is hypothesised to fall to less than 2% of 
normal (Breakefield et al., 2001).
Torsin A may have a role in neuroprotection events within cells, and mutant 
torsin A may both interfere with this function or even be damaging to the cell 
itself (Kuner et al., 2003; Shashidharan et al., 2004). Torsin A is a component 
of Lewy bodies, perhaps further indicating that it has a neuroprotective 
function (Shashidharan et al., 2000). Overexpression of mutant torsin A 
causes the formation of "whorls" within the ER (Hewett et al., 2000), 
although these are not seen at levels of mutant torsin A found in DYT1 
carriers. Torsin A has also been proposed as a factor in stabilising various 
protein kinases which in turn phosphorylate microtubule associated proteins 
such as tau. In this way, torsin A may help to maintain site-directed 
polarization and control neurite outgrowth in cells(Ferrari-Toninelli et al., 
2004).
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In conclusion, these molecular studies demonstrate a particular location for 
torsin A within the brain, and suggest a role for the protein in protein 
chaperoning, membrane interactions, monoamine vesicular function and 
control of neurite outgrowth.
Pathological studies in DYT1
To date, there are few pathological studies in DYT1. Initial studies found no 
pathological abnormalities (Walker et al., 2002). One study has found 
evidence of increased dopamine turnover in the brains of those with the DYT1 
mutation, as indicated by a significant increase in the striatal 3,4- 
dihydroxyphenylacetic acid/dopamine ratio (Augood et al., 2002).
A recent study of the brains of 4 DYT1 positive patients found perinuclear 
inclusion bodies in the midbrain reticular formation and the periaqueductal 
grey matter. The inclusions were located in the pedunculopontine and 
cuneiform nuclei. They stained positively for ubiquitin and torsin A. No 
inclusions were found elsewhere in the brain (McNaught et al., 2004). The 
significance of these findings is uncertain at the present time. It seems 
unusual that inclusions should be localised solely to the brainstem. Clearly 
brainstem motor function as revealed by electrophysiological study is 
abnormal in dystonia. However, it seems difficult to explain the full clinical 
spectrum of dystonia on the basis of brainstem pathology alone.
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Structural imaging studies
Patients with DYT1 dystonia were not found, on routine clinical imaging, to 
have any consistent abnormality in brain structure. However, in parallel with 
imaging in other forms of primary dystonia, more advances structural imaging 
techniques have now been applied to DYT1 mutation carriers. In a recent 
study (Carbon et al., 2004), 12 DYT1 mutation carriers (8 manifesting and 4 
non-manifesting) were subjected to diffusion tensor imaging to assess 
microstructural white matter changes. Fractional anisotropy (FA) values, 
which are thought to reflect microstructural features such as fibre integrity 
and coherence, were calculated for subjects and the results compared with 
controls. Reductions in FA were found in DYT1 subjects in the sensorimotor 
cortex, the posterior splenium and in the right pre-central gyrus. Comparison 
of the manifesting and non-manifesting DYT1 groups revealed a greater 
reduction in the sensorimotor cortex FA in manifesting compared to non­
manifesting subjects.
Functional imaging studies
In 1998, Eidelberg and colleagues used flurodeoxyglucose PET to compare 
patterns of regional glucose metabolism in manifesting and non-manifesting 
patients. At rest they found similar, abnormal patterns of increased 
metabolism in the lentiform nucleus, cerebellum and supplementary motor
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areas which were hypothesised to represent abnormal patterns of activation 
in cortico-striato-cortical loops. It was interesting to note that the patterns of 
abnormality were similar in manifesting and non-manifesting individuals 
despite their clinical differences (Eidelberg et al., 1998). FDG PET is not easily 
amenable to quantification, and therefore the question of degree or severity 
of abnormality is not answered by this study.
The same group have recently published a further functional imaging study in 
DYT1, this time using [11C] raclopride PET, a ligand that binds to the D2 
receptor (Asanuma et al., 2005). Only non-manifesting DYT1 carriers were 
studied, and a reduction in D2 binding of about 15% was found in the 
caudate and putamen. This reduction was less than that observed previously 
in non-DYTl primary dystonia, and the authors propose a possible threshold 
effect of D2 receptor loss on the development of clinical dystonia.
In conclusion, a wealth of electrophysiological and imaging data exists in 
patients with primary dystonia. The overall impression is of a reduction in 
motor inhibitory circuit activity/function evident at many levels of the nervous 
system, but most likely with its origins in the basal ganglia. Sensory system 
function is certainly not normal in dystonia, but it is still unclear whether this 
is a primary feature of dystonia or its consequence.
The discovery of the DYT1 mutation has enabled study of a select group of 
patients with primary dystonia with a homogenous aeitiology. Molecular
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studies have provided intriguing insights into the possible role of torsin A 
within the cell and the problems that mutant torsin A might provide for 
normal cell function. Certainly the localisation of torsin A to dopaminergic cells 
in the substantia nigra provides further evidence for the importance of the 
basal ganglia in primary dystonia. As will be expanded later, there are reasons 
to explore further the ways in which torsin A might affect vesicular function at 
synapses and the effect mutant torsin A might have on temporal and spatial 
(and quantal) neurotransmitter release.
Functional imaging studies in DYT1 have provided clues that clinically normal 
individuals who carry the DYT1 mutation have abnormalities in brain structure 
and function. What is not clear from these studies is how these abnormalities, 
which are also present in manifesting DYT1 gene carriers, relate to the 
appearance of clinical symptoms.
Brain plasticity and dystonia
The data presented above provides a simple model for primary dystonia 
based on the concept of a poorly inhibited motor (or sensori-motor) system. 
However, abnormalities of intracortical inhibition, silent period, reciprocal 
inhibition and abnormal patterns of brain metabolism seen on PET are 
common findings in a number of movement disorders, and do not seem to be 
capable of encompassing many of the unusual clinical features of dystonia. A 
more complete explanation of the pathophysiology of dystonia might be
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gained by considering a prim ary role for abnormal plastic changes in the brain 
as the cause  of the syndrome. First, let us consider some of the basic science 
behind the concept of brain plasticity, and how it is possible to exam ine  it 
experim entally.
Plasticity, in regard to neural systems, can be defined as the ability of a 
system to change in response to stimuli (internal or external), and then to 
maintain that changed state until further stimuli occur. The ability of the 
nervous system to undergo such  plastic changes can be demonstrated 
experimentally by the observation of change in the functional organisation of 
cortical areas in response to stimuli. With regard to the motor system, these 
plastic changes can be demonstrated by observing changes in m otor  "maps" 
in the primary motor cortex (Ml) in response to pathological or physiological 
interventions. Thus, section of facial nerve supply to whiskers in rats can 
produce rapid spread or "bleeding" of the adjacent forelimb representation 
into the vibrissae area, so that forelimb movement occurs via stimulation of 
the whisker cortical area (Donoghue et al., 1990). Learning of motor skills in 
primates and humans is associated with expansion of cortical representation 
of the body parts involved in the motor task. Such changes may only occur 
for the practice of skilled movements, and not simply repetitive sim ple  
movements (Kleim et al., 1998), a point with potential relevance for the 
aetiology of task-specific dystonia.
While there is consensus that plasticity in the motor system can and does 
occur, the mechanism of plastic changes remains the subject of intense 
debate. From an anatomical point of view, the motor cortex provides a 
structure that would seem to allow plastic changes to occur, with spreading 
horizontal fibres (in particular in layer II/III). These would appear to facilitate 
the development of networks across the motor cortex (and non-motor areas 
as well) in response to stimulation (Gilbert et al., 1996).
Donald Hebb is credited with the development of the most widely accepted 
theory regarding plastic changes in the nervous system: "Hebbian plasticity". 
Simply stated, the theory is that increases in synaptic strength occur when 
there is concurrent activity in pre and post synaptic cells (Hebb, 1949). This 
theory would seem only to allow for increases (and hence eventual 
saturation) of synaptic strength. In response to this, Stent (Stent, 1973) 
proposed an addition to this rule, namely that uncorrelated activity in pre- 
and post-synaptic cells would tend to lead to a decrease in synaptic strength.
This "covariance" theory of synaptic plasticity allows bidirectional changes in 
excitability at synapses, but would lead to the rather unphysiological 
consequence that excitability at synapses would tend either to increase 
exponentially, or to sink to zero -  these simple rules do not appear to allow a 
gradation of synaptic strength. Homeostatic mechanisms are proposed that 
maintain the stability of the network, perhaps by "resetting" the boundaries of 
excitability within a particular network. This can be demonstrated
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experimentally in motor learning experiments in rats where extended training 
on a particular task shifted the synaptic modification range of the target cells 
upwards, so that instead of becoming saturated, further increases in synaptic 
strength could occur (Rioult-Pedotti e t al., 2000). Effectively, it appears that 
more the previous history of activity at the synapse, the more difficult it is to 
potentiate it.
Proposed mechanisms of synaptic plasticity
There are a variety of proposed components to synaptic plasticity. Long-term 
potentiation and depression (LTP/LTD) are the most well known of these, but 
it is likely that a number of overlapping processes occur at the synapse that 
allow changes in synaptic function to occur in response to stimulation.
Presynaptic plasticity
Short lasting changes in synaptic efficiency (lasting milliseconds to seconds) 
can occur due to changes at the pre-synaptic level. Short term potentiation 
and depression are thought to relate to changes in the amount and/or 
probablility of transmitter release. Reduction in calcium influx to the pre­
synaptic bulb appears to induce STD, whereas increases in intra-cellular 
calcium concentrations appears to favour STP induction (De Camilli et al., 
2003). The effects of calcium may be direct, or mediated via calcium 
dependent kinases, which in turn alter the activity of synapsin, a protein that
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alters vesicle mobility(Picconi et al., 2003). When activated, synapsin favours 
release of vesicles and experimentally causes STP induction. STD might occur 
via the reduction of phosphoylated synapsin(Geppert et al., 1997). Other 
mechanisms of pre-synaptic plasticity include availability of vesicles (they are 
stored in an immediate and long-term pool), growth of the bouton, and 
number of boutons.
Post-synaptic mechanisms
There are mechanisms that allow short-term post-synaptic plasticity, either to 
favour increases or decreases in synaptic function. AMPA receptors, which are 
blocked by intracellular polyamines, have this block removed when 
depolarisation occurs, allowing short term facilitation of the post-synaptic 
response to excitation (Rozov and Burnashev, 1999; Rozov et al., 1998). 
Desensitization is an opposing process where a proportion of ligand-gated 
channels are rendered inactive for a short period after exposure to an agonist 
(Jones and Westbrook, 1996).
Brain slice preparations have been extensively used to study the mechanisms 
and controls over synaptic plasticity. In the majority of such experiments in 
the motor cortex, stimulating micro-electrodes are placed into layer II/III and 
field potentials are recorded for a given level of stimulus before and after a 
conditioning stimulus. The measured field potentials (FP) are analogous to the 
excitatory post-synaptic potential (EPSP). Changes in the FP in response to
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conditioning provide a direct measure of changes in synaptic strength. This 
approach allows manipulation of conditioning stimuli and physiological 
conditions in order to better understand the mechanisms of synaptic 
plasticity.
Long-term potentiation (LTP) of synaptic strength can be reliably produced in 
animal brain slice preparations by high frequency direct electrical stimulation 
(Bliss and Lomo, 1973). This has led to the extensive study of the molecular 
changes that occur following LTP induction and of methods to alter the 
direction or magnitude of the change in synaptic strength. In summary, these 
studies have found LTP to, in general, be an NMDA receptor dependent 
process, so that pharmacological(Morris, 1989) or genetic(Sakimura et al., 
1995) blockade of these receptors leads to failure of LTP induction. GABA 
clearly plays an important role in LTP induction, in particular in the motor 
cortex, where reduction of GABA using the GABA antagonist bicuculline, is 
typically required for successful induction of LTP(Chen et al., 1994). Other 
important components of successful LTP induction include rate of change in 
intracellular calcium levels (Yang et al., 1999) and the presence of dopamine, 
without which LTP induction is impaired (Kusuki et al., 1997)). The majority of 
these studies have been in hippocampal tissue, although the role of GABA in 
LTP has been most often demonstrated in motor cortical tissue.
Long-term depression is a more recently discovered phenomenon, and is 
typically produced by prolonged periods of low-frequency stimulation (LFS)
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(Lynch et al., 1977). LFS can abolish LTP (a process known as 
depotentiation), and has been proposed as a mechanism of "forgetting" 
(Picconi et al., 2003).
Experimental protocols capable of inducing LTP and LTD in animal brain slices 
have been established. In the case of LTP, high frequency stimulation (Bliss 
and Lomo, 1973) (e.g. 100 pulses at 100Hz repeated every 10 seconds) was 
initially used. However, a more efficient method of LTP induction appears to 
be with patterned or theta burst stimulation. This pattern of stimulation arose 
from the observation that neuronal firing in the hippocampus in cats and rats, 
particularly when exploring novel environments, occurred in bursts of high 
frequency discharges occurring at the theta frequency (4-7 Hz) (Kandel and 
Spencer, 1961). It was proposed that this pattern of firing might represent 
the physiological substrate of learning, and indeed, conditioning paradigms 
based on theta burst patterns appear to be a reliable method of inducing LTP, 
and perhaps more powerful than regular high frequency stimulation (Lynch et 
al., 1977). A typical theta burst pattern is of a burst of 4 pulses at 100Hz 
delivered every 200ms (i.e at 5 Hz) in a train lasting 10 seconds. This train is 
usually repeated after a 10 second pause, usually for a total of ten trains of 
stimulation.
LTD induction is typically achieved via low frequency stimulation at l-5Hz. 
This stimulation is given continuously for 20-30 minutes. Interestingly, high 
frequency stimulation and even theta burst stimulation can induce LTD
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providing the stimulation is given for a long enough period and in a 
continuous, rather than intermittent fashion (Heusler et al., 2000). LTD can 
also be produced using protocols that would usually cause LTP induction by 
changing certain qualities of the brain slice, for example hyperpolarising the 
post-synaptic membrane (Randic e t al., 1993).
Over one hundred molecules have been suggested as playing a role in LTP 
and LTD (Cohen et al., 1991), but it seems most likely that the interaction 
between glutamate receptors, calcium and AMPA receptors forms the basis of 
LTP/LTD in excitatory pathways.
Inducing plastic change in human motor cortex.
Repetitive transcranial magnetic stimulation
Transcranial magnetic stimulation is a non-invasive method of inducing an 
electric current in the brain via the use of a time-varying magnetic field 
applied to the skull. The magnetic field is delivered through a figure-of-eight 
or circular coil held on the surface of the skull.
Single pulses of TMS can, when given at the correct intensity over the correct 
area of cortex, produce a descending volley in the corticospinal pathway and 
muscle activation. However, when a train of pulses is given, changes can be 
produced in the stimulated area of cortex that outlast the period of
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conditioning. This is the case even if the pulses are delivered at sub-threshold 
intensities (i.e intensities of stimulation that produce no recordable muscle 
activation). It is proposed that these changes are analogous to LTD and LTP 
effects produced in brain slices. Direct recording from synapses pre and post 
rTMS is not possible, so at the present time one cannot be certain that the 
observed effects of rTMS are indeed due to LTP/LTD.
A variety of protocols of rTMS have been devised for the induction of long­
term changes in cortical excitability. The major limitation of these protocols is 
that early in the development of rTMS techniques, high frequencies of 
stimulation (20Hz and above) were found to be capable of inducing seizures 
in human subjects(Wassermann et al., 1996), and therefore internationally 
agreed safety guidelines were introduced, restricting the frequency of 
stimulation that could be used in human subjects(Wassermann, 1998). This is 
notable given that the typical protocols of LTP induction in animal brain slices 
use stimulation frequencies of 50-100Hz.
The most commonly used protocol for induction of an LTD-like effect is 1 Hz 
rTMS delivered at 90% resting motor threshold for 20-30 minutes. With this 
protocol, reductions in cortical excitability have been measured lasting for 30- 
40 minutes after the end of conditioning (Chen et al., 1997; Maeda e t al., 
2000b; Touge et al., 2001). These changes have been demonstrated 
electrophysiologically by comparing the size of motor evoked potential 
produced from single pulse cortical stimulation at a set intensity of magnetic
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stimulation before and after conditioning. They have also been demonstrated 
by using positron emission tomography before and after rTMS. A [18F]FDG- 
PET study showed increased glucose metabolism of bilateral primary motor 
areas and left SMA after subthreshold 5-Hz rTMS over left primary motor 
area, indicating that the effects of rTMS are not limited solely to the site of 
stimulation (Peinemann et al., 2000). Similarly, 1-Hz rTMS over left primary 
motor cortex resulted in widespread bilateral decreases in rCBF measured 
with H2150-PET that lasted for at least one hour after stimulation in prefrontal, 
premotor, primary motor cortex and left putamen (Siebner et al., 2003). A 
functional MRI (fMRI) study (Lee et al., 2003) confirmed the widespread 
changes induced by subthreshold 1-Hz rTMS over the primary motor area.
The same study also showed that the contralateral premotor area and the 
unaffected primary sensorimotor area increased their activity to compensate 
for the suppressive effect of the rTMS.
5Hz rTMS has been used to produce LTP-like effects in human cortex. Due to 
technical problems with coil overheating, trains of 5Hz stimulation are 
typically given in an intermittent fashion (Berardelli et al., 1998a; Fierro et al., 
2001). This is notable, as continuous 5Hz stimulation protocols are used to 
induce LTD in animal studies. It seems possible that the intermittent nature of 
these 5Hz protocols is responsible for the direction of effect noted in human 
studies.
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Higher frequency, higher intensity rTMS has been used, for exampie a 20 
pulse train at 20 Hz and 150% RMT (Pascual-Leone et al., 1994). These 
studies have, in general, produced short lasting (seconds to minutes) 
increases in cortical excitability.
Although physiological effects have been noted after rTMS, behavioural 
effects have been elusive. Most studies confirm that there is no effect of 1 Hz 
motor cortex rTMS on simple motor tasks, e.g. finger tapping speed or 
maximal and mean peak force and peak accelerations of finger movements 
(Chen et al., 1997; Muellbacher et al., 2000). Muellbacher et al. (Muellbacher 
et al., 2002) also reported that the retention of behavioural improvement, but 
not the performance of other basic or well practiced motor tasks or recall of 
the newly acquired motor skill, was disrupted by low frequency rTMS on the 
motor cortex. More complicated tasks, such as the serial reaction time task 
(Siebner et al., 1999) may be affected by rTMS. Twenty minutes 1 Hz rTMS 
on the motor or premotor area subtly slowed the reaction time in a visual 
cued choice reaction time task (Schlaghecken et al., 2003). A 10 min train of 
1 Hz rTMS on the motor cortex improved ipsilateral sequential simple finger 
movements (Kobayashi et al., 2004).
Interventional Paired Associative Stimulation (IPAS)
It is possible to produce long-lasting changes in the excitability of motor 
cortical pathways in humans using paired stimulation of a sensory afferent
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(via direct stimulation of the nerve) and the homologous cortical efferent (via 
a single TMS pulse over the correct area of motor cortex). If trains of such 
stimulation are given, then increases and decreases in cortical excitability can 
be produced that outlast the period of stimulation by minutes to hours.
The exact timing of the afferent and efferent pulses are important in 
determining the direction of change in cortical excitability. Sensory stimulation 
preceeding cortical stimulation by 25ms causes an increase in cortical 
excitability, whereas a gap of 10ms causes a decrease in cortical excitability 
(Wolters et al., 2003).
Similar protocols have been used to induce LTP/LTD in animal preparations 
(Baranyi and Feher, 1981; Hess et al., 1996; Hess and Donoghue, 1994). In 
humans, the effects of IPAS can be blocked by NMDA antagonists such as 
dextromethorphan. Such pharmacological studies have not been performed in 
rTMS, and therefore it is possible that the mechanism of effect of rTMS is 
different from that of IPAS.
Direct Current Stimulation
It is possible to produce long-lasting changes in the excitability of the motor 
system through the use of a weak direct current delivered through an 
electrode placed on the scalp over the motor area (Nitsche and Paulus, 2000). 
Depending on the polarity of the current, the direction of change in cortical
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excitability can be altered. With the positive electrode over the motor area 
(anodal stimulation), and increase in excitability can be produced. With the 
negative electrode over the motor area (cathodal stimulation) a decrease in 
cortical excitability is produced (Nitsche and Paulus, 2000).
Plasticity and dystonia
Converging experimental and clinical evidence would suggest a role for 
disordered sensorimotor plasticity in individuals with dystonia. Abnormal brain 
plasticity in dystonia offers an attractive basis for a new hypothesis to explain 
the pathogenesis of dystonia.
Mapping studies
Indirect mapping of motor and sensory cortices has been performed in 
dystonia using functional imaging and trascranial magnetic stimulation 
techniques. In patients with primary dystonia these studies have in general 
found an enlargement or receptive fields and a blurring of margins such that 
representations of adjacent digits, for example, tend to overlap (Delmaire et 
al., 2005; Thickbroom et al., 2003). Abnormal motor maps are not fixed, but 
can change with effective treatment, for example with botulinum toxin 
injections (Thickbroom et al., 2003).
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rTMS and IPAS
rTMS and IPAS have been used to explore differences in the ability to induce 
plastic changes in those with dystonia compared to normal subjects.
Quarteronne and colleagues used interventional paired associative stimulation 
(IPAS) to explore the ability to induce plastic changes in 10 subjects with focal 
hand dystonia and 10 normal subjects (Quartarone et al., 2003). Low- 
frequency median nerve stimulation, paired with suprathreshold transcranial 
magnetic stimulation (TMS) over the optimal site for activation of the 
abductor pollicis brevis (APB) muscle typically induces a long-lasting increase 
in the excitability of corticospinal output neurons, if median nerve stimulation 
is given 25 ms before TMS. Motor evoked potentials (MEPs) were recorded 
from right APB muscle and right first dorsal interosseus (FDI) muscle. Resting 
and active motor threshold, mean MEP amplitude at rest, short-latency 
intracortical inhibition (SICI) at an interstimulus interval of 2 ms and the 
duration of the cortical silent period (CSP) were assessed immediately before 
and after IPAS. In both groups, IPAS led to an increase in resting MEP 
amplitudes which was more pronounced in the right APB muscle. Compared 
with healthy controls, stimulation-induced facilitation of MEP amplitudes was 
stronger in patients with writer's cramp. In addition, only patients showed a 
slight decrease of resting and active motor thresholds after conditioning. It 
therefore appears that it is "easier" to induce plastic change in those with 
dystonia compared to normal subjects using IPAS.
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Siebner and colleagues used rTMS to explore this similar issue(Siebner e t al., 
2003). In this experiment subjects with focal hand dystonia and normal 
controls received 1Hz rTMS or sham stimulation, and then had a PET scan. 
Widespread changes were seen in the cortex which were greater in subjects 
with dystonia compared to controls.
A recent study has assessed homeostatic mechanisms of plasticity in dystonia 
by examining the result of pre-conditioning the motor cortex with either 
anodal direct current stimulation (which tends to enhance subsequent 
conditioning with rTMS) or cathodal direct current stimulation (which tends to 
decrease the effect of subsequent conditioning with rTMS) (Quartarone et al., 
2005). Subjects with focal hand dystonia and normal subjects were given 
these different types of direct current stimulation prior to 1Hz rTMS. As 
expected, in normal subjects anodal DCS enhanced the inhibitory effects of 
subsequent 1Hz rTMS while cathodal DCS reversed the effect of 1Hz rTMS 
and produced facilitation of motor evoked potential. In subjects with focal 
hand dystonia, no reliable effect of cathodal or anodal DCS was demonstrated 
interpreted as a failure of homeostatic plasticity mechanisms in dystonia.
Clinical data
Clinical studies have demonstrated that a proportion of individuals who 
excessively practice a skilled movement pattern, for example professional
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musicians (Frucht, 2004), can develop dystonia in the trained limb. This has 
also been noted in an animal model of dystonia (Byl et al., 1996). Accidental 
or surgical trauma to a body part, which can enhance long-term potentiation 
(LTP) in the somatotopic area of cortex, can in certain individuals either 
induce or worsen pre-existing dystonia (Jankovic, 2001). As further support 
for the hypothesis of a primary pathological role for excessive plasticity in 
dystonia, in the therapeutic setting there has been some limited success 
reported with the use of interventions designed to restore a more normal 
pattern of synaptic connectivity in the sensori-motor system (e.g. limb 
immobilisation (Priori e t al., 2001), Braille reading (Zeuner and Hallett, 2003), 
and constraint-induced movement therapy (Candia et al., 1999)).
Conclusion
The data presented above suggest an important role for abnormal plasticity of 
the sensorimotor system in the genesis of dystonia. An hypothesis that might 
explain these observations is that in dystonia there is an increased propensity 
to form associations between inputs and outputs which leads to activation of 
inappropriate patterns of muscle activity during voluntary movement. It 
should be noted that an increased susceptibility to undergo changes in 
synaptic effectiveness (i.e. increased "plasticity") is compatible with other 
theories of dystonia, such as lack of "surround inhibition" (Mink, 2003; Sohn 
and Hallett, 2004) or disordered sensory "gating" of movement (Kaji, 2001). 
Indeed, one can speculate that such a change at the synaptic level could be
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the underlying reason why such changes develop in the first instance.
Reduced "surround inhibition" would be the consequence of an increased 
tendency to form excitatory connections within sensori-motor pathways, 
whereas lack of sensory "gating" would reflect increased associations between 
sensory inputs and motor outputs that are normally not present in healthy 
subjects.
Although the response of dystonic subjects to indirect tests of synaptic 
plasticity (IPAS and rTMS) has previously been found to be more intense and 
longer-lasting than that of normal subjects (Quartarone et al., 2003; Siebner 
et al., 2003) it is not clear if this represents a primary abnormality in the 
control of synaptic plasticity in dystonia. The mere presence of a particular 
physiological abnormality in dystonic individuals is not sufficient to 
demonstrate its pathogenicity.
Placing abnormalities in the system that regulates plastic changes within the 
motor system in the centre of a model to explain primary dystonia provides 
an attractive hypothesis which is concordant with a wide range of clinical and 
experimental data. The unique model provided by manifesting and non­
manifesting DYT1 gene carriers gives an ideal subject group in which to test 
this hypothesis.
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Chapter 3
Methods
Subject Ascertainment
Manifesting DYT1 mutation carriers were ascertained from a pre-existing 
database of dystonic patients who tested positive for the DYT1 mutation. 
These patients were contacted by telephone and the study was discussed 
with them. In subjects who expressed an interest in the study, and 
arrangement was made to visit them and as many of their family members as 
possible in order to perform clinical evaluation, and to ascertain non­
manifesting DYT1 mutation carriers.
Family members with dystonia were clinically examined and videoed, 
according to the video scheme outlined in the paper describing the Burke- 
Fahn-Marsden dystonia scale. Details on age at onset, precipitants to onset, 
other medical history, progress of dystonia and response to medication and 
other treatment was recorded.
Family members without dystonia were asked to give a blood sample for 
DYT1 mutation analysis on the understanding that no results of the gene 
anaylsis would be made available to them. Subjects who wished to know their 
gene test result were refered for genetic counselling to the clinical genetics
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service at the National Hospital for Neurology: the process of counselling and 
delivery and follow-up of these patients was therefore performed separate 
from the study as part of normal NHS clinical service provision. Subjects were 
informed that both mutation positive and negative subjects would be invited 
to take part in the elctrophbysiological studies, and therefore an invitation to 
take part should not be taken as evidence of mutation carriage.
In practice, many asymptomatic family members knew their mutation status, 
which simplified the potential ethical dilemmas associated with this type of 
study.
For a period of time after discovery of the DYT1 mutation the National 
Hosptial for Neurology provided the only service for DYT1 mutation testing in 
the UK. Because of this, and the fact that many dystonic patients had been 
referred from all over the UK for specialist opinions, the patients eligible for 
enrolment in the study were widely distributed throughout the UK.
Clinical Study -  methods
As part of the patient ascertainment described above, a number of patients 
with dystonia positive for the DYT1 mutation were ascertained who did not fit 
with classical clinical descriptions of patients with DYT1 dystonia. These 
subjects were selected and their clinical course characterised in more detail. 
In addition a review was performed of previously published cases of DYT1
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dystonia to try to better characterise the possible phenotypes associated with 
the DYT1 mutation, and the aspects of the phenotype that were most 
consistent across published cases. This review was performed by simply 
entering the terms "DYTl", "torsin A" and "TOR1A" into Pubmed, and looking 
for any articles that contained clinical details of DYTl positive patients. These 
details were then collated.
Electrophysiological studies -  Methods
Subjects
Many of the same manifesting and non-manifesting DYTl positive subjects 
were used for the three different electrophysiological studies described in this 
thesis. In addition a group of patients with adult-onset primary cervical 
dystonia were used for one electophysiological study.
DYTl subjects were recruited from the pool of patients ascertained in the 
initial phase of the study described above.
We recruited a total of 10 DYTl gene carriers with clinical dystonia (MDYT1) 
from the movement disorder clinics at the National Hospital for Neurology and 
Neurosurgery. Inclusion criteria were 1) genetic analysis positive for the 
typical DYTl mutation, 2) onset of limb dystonia prior to the age of 25 with or 
without subsequent progression, 3) no other cause for dystonia revealed by
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investigation, inciuding imaging and blood tests, 4) no brain, spinal or 
peripheral nerve surgery for dystonia or other cause in the past, 5) no history 
of other neurological disease, 6) no use of botulinum toxin in the past 4 
months. Subjects were permitted to continue their other medications as 
normal during the study. Clinical details of these patients are given in table 
3.1. All patients had clinical dystonia affecting the arm and hand used for 
electrophysiological testing. A total of eight DYTl gene carriers without 
clinical symptoms (NMDYT1) were ascertained by genetic and clinical 
assessment of family members of the MDYT1 group. Inclusion criteria were 1) 
genetic analysis positive for the typical DYTl mutation, 2) clinical absence of 
dystonia confirmed by personal independent assessment of each patient by 
two clinicians, 3) no brain, spinal or peripheral nerve surgery for any cause in 
the past, 4) no history of neurological disease, 5) age over 30. Thirteen 
healthy controls were recruited from a departmental register of volunteers 
and from DYTl mutation negative family members of DYTl positive subjects. 
The average age of those in the MDYT1 group was 49 (SD: 9), in the 
NMDYT1 group was 50 (SD: 8), and in the control group was 42 (SD:7). For 
one set of experiments, we recruited 6 subjects with adult-onset focal 
dystonia affecting the neck (torticollis). The inclusion criteria for this group 
were (i) focal dystonia affecting the neck, with no other neurological disorder; 
(ii) onset age over 40 years; (iii) no brain, spinal or peripheral nerve surgery 
for any cause in the past; (iv) no use of botulinum toxin in the previous 4 
months.
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Table 3.1: Clinical details of the manifesting DYTl positive subjects.
Subject Age
of
Onset
Site of 
Onset
Current 
distribution 
of dystonia
BFM
score
Medication Experiments
Completed
1, Male 12 R arm Generalised 46 None 1 (SP, RI)
2, Female 11 R hand Segmental 12 Clonazepam,
benzhexol
1 ( Id ,  SP, 
RI), 2, 3.
3, Female 10 Lfoot Generalised 44 Benzhexol 1 (ICI, SP, 
RI), 2, 3.
4, Male 6 Lfoot Generalised 74 Diazepam 1(SP)
5, Female 3 Lfoot Segmental 16 None 1 (ICI, SP, 
RI)
6, Male 10 R hand Multifocal 28 None 1 (ICI, SP, 
RI), 2, 3
7, Female 13 Rarm Segmental 18 Levodopa 1 (ICI, SP, 
RI), 2, 3
8, Male 12 R hand Focal 6 Benzhexol 1 (ICI, SP, 
RI), 2, 3
9, Male 9 Rarm Segmental 6 None 1 (ICI, SP, 
RI), 2, 3
10, Male 18 Lleg Generalised 27 None 1 (ICI, SP)
11,
Female
7 R hand Focal 12 None 2 ,3
12, Male 9 R hand Segmental 22 None 2 ,3
BFM score = Burke, Fahn, Marsden Rating scale score(Burke et al., 1985), 
Experiments completed refers to the experiments which the subjects took part 
in (see below).
Electrophysiological Techniques
Different electrophysiological techniques were used in each of the three main 
experiments:
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1. Experiment 1 (Chapter 5) Intracortical inhibition, silent period and 
reciprocal inhibition in normal subjects, manifesting and non­
manifesting DYTl subjects
2. Experiment 2 (Chapter 6) Reciprocal inhibition pre and post 1Hz 
repetitive transcranial magnetic stimulation in normal subjects, 
manifesting and non-manifesting DYTl subjects.
3. Experiment 3 (Chapter 7) Measurement of the time course of motor 
evoked potential changes after continuous theta burst stimulation 
(cTBS) in normal subjects, manifesting and non-manifesting DYTl 
subjects.
These methods are described in turn below.
Experiment 1
Assessments of intracortical inhibition and facilitation (ICI/ICF), cortical silent 
period (SP) and reciprocal inhibition (RI) were attempted in 10 MDYT1 
subjects, 7 NMDYT1 subjects and 13 normal controls. The assessments were 
all performed on the same day with ICI/ICF and SP in one session, and then 
RI in a second session.
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Intracortical Inhibition and Facilitation.
The technique of ICI measures the influence of a sub-threshold "conditioning" 
pulse of transcranial magnetic stimulation (TMS) given over the hand motor 
area on a subsequent supra-threshold "test" pulse given over the same area. 
Experiments in normal subjects have shown that at short interstimulus 
intervals (0-4ms) there is a reduction in the size of the MEP elicited from the 
contralateral first dorsal interosseus (intracortical inhibition)(Kujirai et al., 
1993). At interstimulus intervals of between 7 and 15ms there tends to be an 
increase in the size of the MEP elicited by the supra-threshold stimulus 
(intracortical facilitation)(Kujirai et al., 1993).
Subjects were seated in a comfortable chair. EMGs were recorded from the 
right first dorsal interosseous (FDI) using Ag-AgCI electrodes. EMG activity 
was recorded with a gain of 1000 and 5000. Magnetic stimulation was given 
using a hand-held figure of eight coil connected though a Bistim module 
(Magstim Company, UK) to two magnetic stimulators (Magstim Company,
UK).
The location of the hand motor area was defined by the location on the scalp 
where magnetic stimulation produced the largest MEP from the contralateral 
FDI when the subject was relaxed (the "motor hot-spot"). We defined the 
resting motor threshold as the minimum stimulation intensity over the motor 
hot-spot that could elicit an MEP of no less than 50pV in five out of ten trials.
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We defined the active motor threshold as the minimum stimulation intensity 
over the motor hot-spot that could elicit an MEP of no less than 200jxV in five 
out of ten trials during a voluntary contraction of the contralateral FDI.
The conditioning stimulus was set at 80% of active threshold. The test 
stimulus was set at the intensity of magnetic stimulation required to 
consistently produce an MEP of lmV.
Subjects received in a random order either the test stimulus alone, or 
conditioning-test stimuli at interstimulus intervals of 2, 3, 4, 5, 6, 7 ,10  and 
15ms. Subjects received the stimuli in two blocks of 50 stimuli each. All trials 
in which EMG movement artefact occurred were rejected online, and that 
stimulus condition was repeated.
Silent Period
The SP is a period of EMG silence that occurs in a voluntarily contracted 
muscle following a suprathreshold magnetic stimulation given over the 
contralateral representative motor area. In normal subjects the SP is typically 
120ms, although this can be longer if the stimulation intensity is 
raised(Inghilleri et al., 1993).
EMGs were recorded as described above. A single magnetic stimulation unit 
(Magstim Company, UK) was used to deliver the magnetic pulse through a
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standard figure of eight coil. Motor thresholds were obtained as described 
above.
Subjects were asked to squeeze a 2.5cm block between their thumb and 
index finger. Visual feedback on the intensity of muscle contraction was 
provided to the subjects, and they were instructed to maintain a constant 
muscle contraction at about 30% of maximum.
Magnetic stimulation was applied over the contralateral hand motor area at 
120% of rest threshold. Twelve stimulations were recorded for each subject. 
The SP was calculated by measuring the time from the end of the MEP to the 
reappearance of EMG activity in excess of 20pV. Those trials where voluntary 
muscle activation exceeded or was less than 30% of maximum were rejected 
online, and the stimulus was given again.
Reciprocal Inhibition
RI assesses the interaction between stimulation of the radial nerve supplying 
the extensor muscles of the forearm and the H reflex produced by stimulation 
of the median nerve. At particular inter-stimulus intervals, a reduction in the 
size of the H reflex occurs in normal subjects(Day et al., 1984). We grouped 
these interstimulus intervals into three phases of RI, one occurring at 0ms, 
one at 10-20ms and one at 70-750ms.
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We attached Ag-AgCI electrodes to extensor digitorum communis, and to 
flexor carpi radialis. Electric pulses were supplied by two constant current 
generators (Digitimer, UK). One electrical stimulator was used to stimulate the 
median nerve in the antecubital fossa. Stimulation duration was lOOOps, and 
the intensity used was that which produced the maximum size of the H reflex. 
The second electrical stimulator was used to stimulate the radial nerve above 
the elbow. The duration of the stimulus was 500ps, and the intensity used 
was that which produced a EMG response of greater than 50pV from extensor 
digitorum communis.
We recorded H reflex size during stimulation of the median nerve alone, and 
for interstimulus intervals of -1 , 0, 3, 5, 10, 20, 30, 50, 70, 100, 300, 500 and 
750 ms. Stimuli were given in a random order in one block of 60 trials and 
two blocks of 50 trials. Any trials where EMG movement artefact occurred 
were rejected online, and were repeated.
Statistical Analysis
To assess ICI and ICF, repeated-measures analysis of variance (ANOVA) was 
used. Because inhibition and facilitation at particular interstimulus intervals 
have different mechanisms, we grouped means at an "inhibitory" interval 
(average of 2, 3, and 4ms interstimulus intervals), an "intermediate" interval 
(average of 5 and 6ms interstimulus intervals), and a "facilitatory" interval 
(average of 7 ,10  and 15ms interstimulus intervals).
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To assess SP, one-way analysis of variance was used to compare the three 
groups.
To assess RI, a two-way ANOVA was used to compare the data between the 
three groups at each of three interstimulus intervals: "first phase" 
(interstimulus interval of Oms), "second phase" (average of interstimulus 
intervals 10 and 20ms) and "third phase" (average of interstimulus intervals 
70-750ms).
Not all subjects were able to participate in all the experiments. Subjects 4 and 
10 had no consistent H reflex, and therefore reciprocal inhibition (RI) could 
not be assessed in them. In subjects 1 and 4, assessments of ICI/ICF were 
confounded by movement artefact. One subject in the NMDYT1 group also 
did not have a consistent H reflex, and therefore could not have RI assessed. 
Statistics were performed using SPSS for Windows 10.0.
Experiment 2
Eight MDYT1 subjects (see table 3.1), 6 NMDYT1 subjects and ten healthy 
controls were recruited for this experiment.
Reciprocal inhibition (RI) was recorded from subjects using the same method 
as described above. Following this assessment of RI, 1Hz rTMS was given
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over the pre-motor area. The pre-motor area was defined in relation to the 
motor hand area, defined as the location on the scalp where magnetic 
stimulation reproduced the largest MEP from the contralateral first dorsal 
interosseous (FDI) when the subject was relaxed (the "motor hot-spot"). We 
defined the resting motor threshold as the minimum stimulation intensity over 
the motor hot-spot that could elicit an MEP of no less than 50pV in five out of 
ten trials. The pre-motor area was defined as an area 2.5cm anterior to the 
motor hot spot. RTMS was administered using a flat figure-of-eight-shaped 
magnetic coil (outer diameter of each wing: 9.5 cm). The coil was held 
tangentially to the skull with the handle pointing backward and laterally at a 
45 degree angle to the sagital plane.
1200 pulses of rTMS at 1Hz were delivered to the pre-motor area at an 
intensity of 90% of resting motor threshold. Stimulation was provided by a 
Magstim rapid stimulator connected to four booster modules (Magstim 
Company, UK). The pulse waveform was bi-phasic.
Following the period of rTMS, RI was immediately re-assessed using the 
paradigm described above.
Statistical Analysis
Statistics were performed on grouped data from the whole time course of RI: 
the first phase of inhibition was defined as inhibition at ISI = 0 ms; the 
second phase as ISIs = 10, 20 ms; the third phase of inhibition was defined
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as the mean inhibition over ISIs = 75 -500 ms. We took the a priori view that 
the three phases of RI were due to different mechanisms, and therefore 
performed a two way ANOVA with GROUP (patients vs. controls) and TIME 
(before vs. after rTMS) as main factors. This two-way analysis was followed 
by paired t tests to probe the nature of any interaction. Statistics were 
performed using SPSS for Windows 10.0.
Experiment 3
Eight MDYT1 subjects, 6 NMDYT1 subjects, 7 subjects with adult onset 
cervical dystonia and 7 healthy control subjects were recruited.
Subjects were seated in a comfortable chair. Ag-CI electrodes were attached 
to the dominant first dorsal interosseous muscle (FDI) (the right hand in all 
subjects) using a belly-tendon montage. EMG signals were amplified using a 
gain of 1000 and 5000 via a Digitmer amplifier (Digitimer, UK).
We identified the "motor hot-spot" relating to the dominant FDI using a single 
magnetic stimulator (Magstim 200, Magstim Company, Dwyfed, UK) 
connected to a hand-held figure of eight coil with an outer winding diameter 
of 70mm. The coil was held with the handle pointing in the anterior-posterior 
plane, which is thought to preferentially activate neurons transynaptically. The 
motor hotspot for the FDI was defined as the area on the scalp where a 
magnetic stimulus of a set intensity produced the largest size of MEP from the
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contralateral FDI. This spot was marked on the scalp. The intensity of the 
magnetic stimulus was adjusted to produce a MEP of approximately lmV for 
each subject, and this intensity was used for all assessments of MEP size for 
the rest of the experiment.
The active motor threshold (AMT) was calculated as the minimum intensity of 
magnetic stimulation given over the motor hotspot capable of producing an 
MEP of greater than 200pV in 5 out of 10 trials while subjects were 
performing a voluntary contraction of FDI at about 20-30% of maximum. A 
constant level of muscle contraction was achieved by the use of visual 
feedback.
rTMS
Repetitive transcranial magnetic stimulation (rTMS) was delivered using the 
same figure of eight coil described above connected to a Rapid-stim machine 
(Magstim Company, Dwyfed, UK) and four booster modules. We used a novel 
paradigm of rTMS based on theta burst patterns (see A ppen d ix  1 for a full 
description of this technique). The basic theta burst pattern used was a train 
of three 50Hz pulses given every 200ms (i.e. at 5Hz). This pattern was given 
in a continuous fashion for 20 seconds (a total of 300 pulses). The intensity of 
this stimulation was 80% of AMT. We have previously found this pattern of 
stimulation capable of producing consistent MEP suppression for about 20 
minutes following the end of stimulation.
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For each subject we measured MEP size in response to single pulse 
stimulation delivered at the set intensity described above. 30 MEPs were 
recorded in this fashion, and the resulting mean MEP size defined the baseline 
excitability of the hand motor area.
rTMS was then delivered according to the paradigm described above. 
Immediately after the end of rTMS, and at five minute intervals after this, a 
block of 15 MEPs was recorded by stimulation of the hand motor area using 
the same intensity of stimulation used in the baseline assessment of MEP. 
Recording was continued every five minutes until 35 minutes after rTMS.
Mean MEP size was calculated for each subject for each five minute interval 
after rTMS. MEPs were normalised with respect to baseline MEP size. Group 
differences in change in MEP size following rTMS were assessed using a 2 way 
ANOVA with TIME (time following rTMS) and GROUP as main factors. 
Independent sample t-tests were used for post-hoc comparisons. Statistical 
analysis was performed using SPSS for Windows version 11.0.
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Chapter 4
Clinical data obtained during ascertainment of patients for electrophysiological 
studies.
During patient ascertainment for this study, a number of families with DYT1 
dystonia were reviewed, and we identified a number of patients with 
phenotypes in DYT1 positive individuals that did not fit with the "typical" 
phenotype said to be associated with the mutation. Example case histories of 
five such patients are given below. This prompted us to analyse all previously 
reported patients with DYT1 dystonia with regard to clinical presentation and 
course, in order to better characterise the range of phenotypes associated 
with the DYT1 mutation.
Case 1: Late Presentation
This 71-year-old man was of Ashkenazi Jewish origin, and had a normal birth 
and early development. He was well until his mid-thirties, and worked in the 
financial sector at a job that required a significant amount of writing by hand. 
At the age of 35 he noticed for the first time that his writing had deteriorated 
due to the onset of tremor in the right hand. Over the next two years, the 
tremor spread to involve the left hand also. These symptoms were stable until 
the age of 69 when he noticed a worsening of the tremor in his left hand so
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that he was unable to perform routine tasks with that hand. Family history 
was positive for bilateral arm dystonia in his son, also with late onset in his 
thirties. His son was positive for the DYT1 mutation.
Examination at the age of 71 revealed a clear rest tremor of both arms. The 
tremor was more severe on posture, and was coarse and proximal in nature. 
When attempting to write he had an abnormal grip with aggravation of the 
tremor. There was mild dystonic posturing of the left hand when the arms 
were outstretched. Since there had been late worsening of the tremor, the 
diagnosis of Parkinson's disease was considered. However, a Dopamine 
Transporter scan (DAT SPECT) was normal.
Case 2: Late presentation triggered bv injury
This 68-year-old woman was entirely well until the age of 38, working in a 
department store and bringing up a family. She had never noticed any 
difficulty in walking. At the age of 38 she tripped and twisted her left ankle. 
Within a few days following this injury she developed inversion and plantar 
flexion of the left foot on walking that has persisted to the present day. No 
other symptoms emerged until the age of 60 when she noticed that her voice 
had become hoarse.
Her sister and her nephew both had early-onset dystonia, and were positive 
for the DYT1 gene abnormality. Her father was said to have had "weak 
ankles" and wore a splint on his left foot.
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Examination revealed a clear dystonic posturing of the left foot on walking. In 
addition, her speech was dystonic with a harsh voice and inaccurate 
articulation of certain sounds. The rest of the examination was normal.
Case 3: Late Progression.
This 65-year-old right-handed woman is the sister of Case 2 above. After a 
normal early development, she developed inversion of the left foot at the age 
of five. She had no problem with her general functioning apart from a slightly 
unusual gait.
At the age of 59 she began to develop problems with writing. Although she 
had previously been noted to have some dystonic posturing of the right arm 
that manifested when walking, her right hand had not been affected and she 
had been able to write without difficulty all her life. At the age of 59 for the 
first time she noticed that her hand began to adopt an unusual posture during 
writing, and that the quality of her handwriting had deteriorated, so that she 
was prompted to seek medical attention.
On examination she had tremulous dystonia of the left foot at rest and on 
walking. The right leg was mildly affected. She had a mild postural tremor of 
the right arm, and clear dystonic posturing of the right hand during writing.
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Case 4: Onset of Dvstonia after Drugs.
This 67 year old woman was well until the age of 47. She then developed 
problems with low mood and suffered episodes of mania. Manic depression 
was diagnosed, and after initial treatm ent with benzodiazepines, haloperidol 
was introduced. One year later, when she was 50, she noticed that her head 
was turning involuntarily to the left while she was walking. Over the next year 
she noticed the gradual onset of abnormal posturing of her right foot and 
spine when walking. In addition, the quality of her voice changed with her 
articulation becoming less clear. Her symptoms then stabilised, and have not 
changed since.
Her family history was positive for early onset dystonia in two of her three 
children, both of whom were positive for the DYT1 mutation. Her son 
developed limb dystonia at the age of seven with subsequent generalisation, 
including spread to craniocervical and bulbar muscles. Her daughter 
developed dystonia in the right hand at the age of 18, manifesting mainly on 
writing and playing the trumpet. She is now 25 and has developed no further 
symptoms. There was no family history of dystonia in the parents or 
grandparents of case 4.
Examination revealed torticollis to the left, exacerbated by walking, as well as 
mild right foot dystonia and moderate axial dystonia. She had dystonic 
involvement of her speech.
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Case 5: Severe Bulbar involvement
This 19 year old man was well until he developed dystonic posturing of the 
right arm at the age of seven. The dystonia became generalised within one 
year and was severe involving all four limbs and with a very marked axial 
dystonia producing retrocollis and an opisthotonic posture. His dystonia 
proved refractory to treatm ent with benzhexol, tetrabenazine, L-dopa, 
clonazepam and baclofen.
At the age of 13, he developed progressive bulbar involvement with 
dysarthria and problems with swallowing. These problems became severe, 
and resulted in frequent chest infections secondary to aspiration. A 
gastrostomy tube was inserted when he was 17 years old as swallowing even 
thickened fluids was unsafe.
Due to his severe bulbar involvement, secondary dystonia was suspected and 
he was investigated accordingly. However, all tests were normal, including MR 
imaging of his brain. When DYT1 testing became available, he was found to 
be positive for the typical GAG deletion. There was no family history of a 
similar disorder.
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Bilateral globus pallidus internus stimulators were inserted in 2001. He has 
made a significant improvement since this time, so that he is now swallowing 
and speaking well, and has noted a marked reduction in limb dystonia.
Review of previously published cases with DYT1 dystonia
Prompted by these unusual cases, we undertook a review of previously 
published cases with the DYT1 mutation (table 1.3) The number of cases 
reported to date is small (219 cases), and some of these cases may have 
been reported simply because they are unusual, perhaps biasing the cases in 
the literature towards those that are atypical (Brassat et al., 2000; Bressman 
et al., 2000; Gasser e t al., 1998; Gatto et al., 2003; Ikeuchi et al., 1999; Im 
et al., 2004; Kabakci et al., 2004; Kamm et al., 1999; Kamm et al., 2000; 
Lebre et al., 1999; Leube et al., 1999; Leung et al., 2001; Major et al., 2001; 
Matsumoto et al., 2001; Nomura et al., 2000; Opal et al., 2002; Slominsky et 
al., 1999; Valente e t al., 1998; Wong et al., 2005). However, studies with 
larger numbers of unselected patients such as those by Bressman (Bressman 
et al., 2000), Lebre (Lebre et al., 1999),Slominsky (Slominsky et al., 1999) 
and Valente (Valente e t al., 1998), show how variable the phenotype can be. 
However, amongst this variability, two clinical features stand out in their 
relative constancy: 1) onset of symptoms before the mid-twenties, and 2) 
onset of dystonia in a limb. Age of onset of dystonia in the reported cases 
ranges from 4 months (Nomura et al., 2000) to 64 years of age (Opal et al., 
2002). However, despite this large range, onset after the mid twenties is rare
85
(only 20 out of 219 reported cases (9%)), and in most the onset is in late 
childhood or early teens. Onset of dystonia almost always occurs in a limb, 
although four cases with onset in the neck (Bressman et al., 2000), one case 
with onset in the larynx (Bressman et al., 2000) and one case with onset in 
the trunk (Ikeuchi et al., 1999) have been reported. Overall, onset appears to 
be just as likely to occur in the upper limb as the lower limb, although in the 
unselected largely English cohort reported by Valente (Valente et al., 1998) 
only 14% of patients had onset in the leg. The impression that non-Jewish 
DYT1 positive individuals are more likely to have onset in the arm than the leg 
is not supported by Bressman's large sample (Bressman et al., 2000). In this 
study, a comparison of site of onset between Jewish (n=52) and non-Jewish 
(n=45) individuals, showed that 37% Jewish individuals had onset in the leg, 
compared to 60% of non-Jewish individuals.
Thus, most of the variability seen in the reported cases of DYT1 dystonia is 
actually in the clinical pattern (distribution) of the dystonia. Although 
progression to generalised dystonia appears to be the norm, from our review 
the number of cases remaining with focal dystonia after prolonged follow-up 
is striking (21% of Bressman's sample), as is the frequency of cranio-cervical 
involvement (9-40% in the larger unselected studies). The relatively low 
frequency of progression to generalised dystonia in Bressman's study (57%) 
may reflect a more stringent application of the clinical categorisation of 
dystonia compared to other studies, as 10% of their sample are reported to 
have multifocal dystonia, and 12% segmental dystonia.
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Table 3.1: Summary of previously published cases of DYT1 dystonia
Study No o f Patients Mean age at onset in 
years (SD)
Site o f onset % (n) Progression % (n) Mean length o f follow 
up (SD)
Cranial Involvement? 
% (n)
Wong (2005) 1 4 Leg Generalised 6 No
Im (2004) 5 13(5)
Range 7-20
Arm: 40% (2) 
Leg: 40% (2) 
Neck 20% (1)
Generalised: 60% (3) 
Segmental: 20% (1) 
Focal: 20% (1)
Not stated Yes: 40% (2) 
No: 60% (3)
Kabakci (2004) 5 13(10.2) 
Range 2-31
A rm : 60% (3) 
Leg: 40% (2)
Generalised: 80% (4) 
Segmental: 20% (1)
Not stated Yes: 60% (3) 
No: 40% (2)
Gatto (2003) 1 9 Arm Segmental 37 No
Matsumoto (2001) 6 13.7(10.5) 
Range 9-35
Arm: 66.6% (4) 
Leg: 33.3% (2)
Generalised: 50% (3) 
Focal: 50% (3)
14.2(18.2) 
Range 1-49
Not Stated
Major (2001) 3 13.3 (3.5) 
Range 10-17
Arm: 66.6% (2) 
Leg: 33.3% (1)
Generalised:66.6% (2) 
Segmental: 33.3% (1)
24(15.3) 
Range: 7-37 yrs
Yes: 66.6% (2) 
No: 33.3% (1)
Bressman (2000) 97 14(9)
Range: 4-44
Leg: 47.4% (46) 
Arm: 48.5% (47) 
Neck: 3.1% (3) 
Larynx: 1.0% (1)
Generalised:56.7%(55) 
Multifocal: 10.3% (10) 
Segmental: 12.4%(12) 
Focal: 20.6%(20)
25yrs (15.7) 
Range not stated
Yes: 9.3% (9) 
No: 90.7% (88)
Nomura (2000) 10 11.1 (6.1) 
Range 0.33-18
Leg: 20% (2) 
Arm: 80% (8)
Generalised: 50% (5) 
Segmental: 10% (1) 
Focal: 40% (4)
22(13.9) 
Range: 7-48
Yes: 20% (2) 
No: 80% (8)
Brassat (2000) 5 8.6 (3.04) 
Range: 6-12
Leg: 40% (2) 
Arm: 60% (3)
Generalised: 80% (4) 
Segmental: 20% (1)
22.5(18) 
Range: 1.5-45
Yes: 80% (4) 
No: 10% (1)
Lebre (1999) 10 9(4)
Range: 5-20
Arm: 90% (9) 
Leg: 10% (1)
Generalised: 70% (7) 
Segmental: 20% (2) 
Focal: 10% (1)
22(17)
Range: 3-45 yrs
Yes: 40% (4) 
No: 60% (6)
Leube(1999) 3 12.7 (4) 
Range 9-17
Leg: 66.6% (2) 
Arm: 33.3% (1)
Generalised:66.6% (2) 
Focal: 33.3% (1)
Not Stated Yes: 33.3% (1) 
No: 66.6% (2)
Slominsky (1999) 24 Not Stated Not Stated Generalised: 92%(22) 
Focal: 8% (2)
Not Stated Not Stated. One 
patient with stuttering 
only.
Kamm (1999) 4 9.8 (5.1) 
Range: 5-17
Leg: 50% (2) 
Arm: 50% (2)
Generalised: 75% (3) 
Multifocal: 25% (1)
14.3 (10.6) 
Range: 2-25
Yes: 0% (0) 
No: 100% (4)
Ikeuchi(1999) 1 13 Shoulder/Trunk Axial dystonia 12 Yes
Valente (1998) 22 9.9 (4.3) 
2-21
Leg: 86.3% (19) 
Arm: 13.6% (3)
Generalised:86.3%( 19) 
Segmental: 9% (2) 
Focal: 4.5% (1)
Not Stated Yes: 29% (4) 
No: 79% (18)
Gasser (1998) 5 14.9(10.9) 
Range: 9-38
Leg: 0%
Arm: 100% (5)
Focal: 80% (4) 
Unknown: 20% (1)
22.5 (7.9) 
Range: 12-28
Yes: 0% (0) 
No: 100% (5)
Guidelines relating to the testing of patients with dystonia for the DYT1 gene 
have been proposed (Bressman et al., 2000). These guidelines were based on 
DYT1 testing in a cohort of 267 individuals with primary torsion dystonia, 168 
of whom were of Ashkenazi Jewish descent. Notable differences in the ability 
of clinical characteristics to predict DYT1 positivity were observed between 
Jewish and non-Jewish individuals. When using age of onset of dystonia 
before the age of twenty-six as the sole criterion for DYT1 testing, specificity 
in the non-Jewish cohort was only 43%, compared to 63% in the Jewish 
cohort. Using "onset in a limb" as the sole criterion for testing gave a 
specificity in the non-Jewish cohort of only 56%, compared to 81% in the 
Jewish cohort. Combination of these two factors gave a specificity of 69% for 
the non-Jewish cohort and 88% for the Jewish cohort. This would argue for a 
modification of the guidelines for DYT1 testing in non-Jewish individuals with 
dystonia. Age of onset prior to the age of 26 is probably not a sufficient factor 
on its own to guide DYT1 testing in non-Jewish individuals, and should be 
combined with onset of dystonia in a limb. This reflects the lower gene 
frequency of the DYT1 mutation in the non-Jewish population. In fact, the 
DYT1 mutation may not be the commonest cause of early-onset generalised 
dystonia in the non-Jewish population. A recent study of presumably non- 
Jewish children with limb-onset dystonia with an average age of onset of 8 
found only 5 out of 30 (17%) to carry the GAG deletion (Zorzi et al., 2002).
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We can apply the above guidelines to the 5 individuals reported here who had 
unusual phenotypic presentation of dystonias associated with the DYT1 
mutation. Case 1 had onset of dystonic (initially task-specific) tremor in his 
thirties but with clear worsening much later in life, which was the unusual 
aspect. In fact, it was wondered whether he might have incidental 
Parkinison's disease, but a DAT SPEC!" scan was normal. Despite the late 
worsening of his symptoms, the onset of the symptoms was in a limb, and the 
phenotype resembled that seen in primary dystonia, suggesting that the 
clinical syndrome in this patient was due to the DYT1 mutation rather than 
another cause.
Case 2 had onset of dystonia in the foot following trauma, with later 
involvement of the larynx. There has been considerable debate concerning 
the role that environmental factors (particularly trauma) might play in 
triggering symptoms in other forms of primary dystonia, but little is known 
about their role in the onset of dystonia in DYT1 gene carriers. A report of 
monozygotic twins with familial adult-onset craniocervical dystonia suggested 
that trauma might have played a role in the greater severity of dystonia in 
one of the twins (Albanese et al., 2000). Epidemiological studies of patients 
with blepharospasm have implicated facial trauma as a risk factor for the 
development of the condition (Defazio et al., 1999). The triggering of primary 
dystonia by trauma should be differentiated from acute post-traumatic 
dystonia, which leads to a relatively fixed dystonia, the absence of sensory 
gestes and a poor response to botulinum toxin (Goldman and Ahlskog, 1993;
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Tarsy, 1998). In case 2, there was a clear temporal relationship between 
peripheral trauma and onset of dystonia in the injured limb. The dystonia 
affecting the foot was not of a fixed type, and was only noticeable during 
walking. Some years later she developed evidence of laryngeal dystonia. This 
clinical presentation therefore suggests that her dystonia was primary 
dystonia due to the DYT1 mutation, triggered by injury, rather than acute- 
post traumatic dystonia with coincidental DYT1 positivity. This is interesting, 
as it might suggest a role for environmental factors in the phenotypic 
penetrance of the DYT1 gene.
Although case 3 had a typical onset of DYT1 dystonia, she developed late 
progression of dystonia in the right hand, which is unusual. Similarly to case 
1, the dystonia progressed in a limb with a phenotype similar to that seen in 
primary dystonia, suggesting a causal role for the DYT1 mutation in this case. 
There was no apparent triggering factor for the progression of the dystonia.
In case 4, there was a temporal relationship between neuroleptic drug use 
and the onset of dystonia. It could be argued that the observed clinical 
phenotype was due to tardive dystonia, and that the DYT1 mutation was not 
pathogenic. This argument is supported by the site of onset of the dystonia 
(the neck), and the similarity of the phenotype to that seen in tardive 
dystonia (mainly axial involvement). However, it is possible that the presence 
of the DYT1 gene in this patient increased her susceptibility to developing
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dystonia following neuroleptic drug use. The true pathogenesis of the dystonic 
syndrome in this case therefore remains unclear.
Our fifth case had bulbar involvement, severe enough for PEG insertion to be 
required, early on in the course of progressive dystonic symptoms. He 
otherwise had a typical presentation of DYT1 dystonia with onset of dystonia 
in a limb below the age of 26, with subsequent generalisation. Early bulbar 
involvement is usually a "red flag" to consider secondary dystonia, but this 
case demonstrates that DYT1 dystonia can occasionally also manifest with 
severe bulbar involvement.
The low phenotypic penetrance of DYT1 dystonia creates a diagnostic 
difficulty in patients with atypical clinical presentations who are positive for 
the DYT1 mutation. Some such patients may in fact be true asymptomatic 
carriers of the DYT1 gene, and simply have another unrelated cause for their 
clinical syndromes. For example, a patient with a psychogenic movement 
disorder in association with the DYT1 mutation has been reported (Bentivoglio 
et al., 2002). If more were known about the genetic and/or environmental 
determinants of penetrance in DYT1 dystonia then it would be possible to 
determine in which of these atypical clinical cases the DYT1 mutation was 
pathogenic. At the present time, however, it seems sensible that the onset of 
dystonia in a limb, and the similarity of the clinical phenotype to that seen in 
primary dystonia are useful factors that point towards the clinical syndrome 
being a true manifestation of the DYT1 mutation.
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In general, therefore, the guidelines for DYT1 testing proposed by Bressman 
(Bressman et al., 2000) seem reasonable. For non-Jewish individuals, the 
addition of "limb onset" to age of onset would be likely to improve the 
specificity of the guidelines. A positive family history of early-onset dystonia 
should swing the balance towards DYT1 testing in family members with late- 
onset dystonia or other atypical presentations. However, as cautioned above, 
DYT1 positivity in such individuals does not necessarily imply a causal 
relationship between the observed clinical syndrome and the DYT1 mutation. 
Limb onset of dystonia and a phenotype typical of primary dystonia provide 
supporting evidence for such a relationship.
This review of reported cases of DYT1 dystonia does /7<tf answer some 
important questions raised by the five unusual cases that we have presented. 
Does late progression of symptoms occur in other cases of DYT1 dystonia, 
and if so, how common is this? This is important in counselling patients with 
DYT1 dystonia about their likely prognosis. Are environmental triggering 
factors such as trauma or drugs important in the genesis of dystonic 
symptoms? If so, then there are implications for asymptomatic gene carriers 
to, if possible, avoid exposure to such triggers. Further detailed studies 
assessing the clinical characteristics of manifesting and non-manifesting DYT1 
positive individuals will help to define the full range of the DYT1 phenotype, 
and will therefore aid diagnostic and gene testing decisions in the future.
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Chapter 5
Cortical, brainstem and spinal inhibition in DYT1 mutation carriers.
The following experiments address the hypotheses outlined in chapter 1:
1. That manifesting gene carriers would have similar abnormalities in cortical 
and spinal motor inhibitory function as previously described in non-genetically 
characterised primary dystonia.
2. That non-manifesting gene carriers do not develop symptoms as the DYT1 
mutation has no consequences for them (perhaps as it is inactivated by some 
mechanism).
3. That electrophysiological abnormalities are present in non-manifesting gene 
carriers that affect similar systems to those seen in manifesting gene carriers, 
but are of a lesser severity, and do not reach the threshold for clinical 
symptoms to be produced.
4. That non-manifesting gene carriers have only a sub-set of the 
pathophysiological abnormalities present in manifesting gene carriers, and 
these are not sufficient to produce clinical symptoms.
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Results
Intracortical Inhibition and Facilitation (ICI and ICF)
ICI/ICF was compared in 8 MDYT1, 7 NMDYT1 and 8 control subjects. The 
complete time course at all interstimulus intervals (ISI) is shown in figure 3.1a 
with grouped data (inhibitory, intermediate and facilitatory ISIs) in figure 
3.1b. Repeated measures ANOVA was performed on grouped data with group 
(MDYT1, NMDYT1 and controls) and ISI (inhibitiory, intermediate and 
facilitatory) as main factors. As expected, ANOVA showed a highly significant 
effect of ISI [F(2,40)=68, p<0.001], but there was also a significant 
interaction between group and ISI [F(4,38)=3.5, p<0.05]. Post hoc analysis 
showed that there was significantly less inhibition in MDYT1 and NMDYT1 
subjects compared to controls in the inhibitory interval [F(l,13)=6.8, p<0.05 
and F(l,13)=5.7, p<0.05 respectively]. There were no significant differences 
found at the inhibitory interval between MDYT1 and NMDYT1 subjects. No 
significant differences were found between controls and either group of 
subjects at the intermediate or facilitatory intervals.
94
Figure 5.1a and b: Intracortical inhibition and facilitation for MDYT1, NMDYT1 
and control subjects. Figure 5. la shows the size of MEP as a percentage of 
the unconditioned size at all interstimulus intervals. Figure 5. lb shows the 
mean size of MEP as a percentage of the unconditioned size at the inhibitiory, 
intermediate and facilitatory intervals. Error bars represent standard error of 
the mean.
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Cortical Silent Period (SP)
SP was assessed in 10 MDYT1, 6 NMDYT1 and 8 control subjects. Results are 
shown in figure 3.2. Oneway ANOVA was performed on the data, and 
demonstrated a significant effect of group on the length of the silent period 
[F(2,21)=3.9, p<0.05]. Post hoc analysis using independent sample t  tests 
was then performed. The SP was shorter in both groups of gene carriers 
compared to controls (MDYT1 subjects: t=-2.3, p<0.05; NMDYT1 subjects: 
t=-2.5, p<0.05), but no significant differences in SP were found between 
MDYT1 and NMDYT1 subjects.
Figure 5.2: Silent period duration for MDYT1, NMDYT1 and control subjects. 
Error bars indicate standard error of the mean.
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Reciprocal Inhibition (RI)
RI was assessed in 8 MDYT1, 6 NMDYT1 and 13 control subjects. The 
complete time course of RI a t all ISI is shown in figure 5.4a, with grouped 
data in figure 5.4b. Repeated measures ANOVA was performed with group 
(MDYT1, NMDYT1 and controls) and ISI as main factors. A significant 
interaction between group and ISI was found [F(2,20)=4, p<0.05]. Post hoc 
analysis on grouped data showed no significant differences between the three 
groups in the first phase of RI [F(2,24)=0.441, ns]. However, a significant 
difference was found between MDYT1 and controls in the second phase 
[F(l,15)=6, p<0.05] and in the third phase [F=(l,15)=4.6, p<0.05]. NMDYT1 
subjects were not significantly different from controls in any of the three 
phases of RI.
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Figure 5.4a shows the H  reflex size as a percentage o f the unconditioned size at 
all interstimulus intervals. Figure 5.4b shows mean data for the H  reflex size as 
a percentage o f the unconditioned size at each o f the three phases o f reciprocal 
inhibition. Error bars indicate standard error o f the mean.
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Discussion
These experiments demonstrated for the first time that electrophysiological 
abnormalities of cortical excitability exist in both manifesting and non­
manifesting carriers of the DYT1 gene. Manifesting and non-manifesting 
carriers had reduced ICI and shorter cortical silent periods, but the second 
and third phases of RI were only abnormal in manifesting gene carriers. We 
conclude that the DYT1 mutation produces subclinical physiological deficits in 
non-manifesting carriers, which are not as widespread as those seen in 
manifesting patients. This would be consistent with the hypothesis that 
additional genetic/environmental insults are necessary to produce clinical 
dystonia in gene carriers.
Changes in manifesting carriers of the DYT1 mutation.
Previous physiological studies of non-genetically characterised individuals with 
dystonia have revealed a variety of abnormalities in inhibitory mechanisms at 
many levels of the CNS(Berardelli et al., 1998b). These changes are thought 
to be the result of a functional disturbance in basal ganglia function that 
causes altered thalamic control of cortical motor areas and abnormal 
regulation of brainstem and spinal cord inhibitory mechanisms. The present 
experiments examined a selection of cortical and spinal circuits in manifesting 
carriers of the DYT1 mutation, and found a similar pattern of abnormalities. 
The reduced ICI is likely to reflect a decrease in the excitability of intrinsic,
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probably GABAa, circuits in the motor cortex (Ziemann et al., 1996c) whilst 
the shorter SP is likely to be due to changes in a different cortical inhibitory 
circuit that may involve GABAb mechanisms(Ziemann et al., 1996c). Spinal 
reciprocal inhibition depends in its first part on disynaptic postsynaptic 
inhibition whereas presynaptic inhibition of la terminal is important in its 
second part. The nature of the third phase of inhibition is unresolved. The 
present data showing a normal first phase of inhibition and reduced later 
phases is compatible with the original description of Nakashima et al in non- 
genetically characterised dystonia(Nakashima et al., 1989).
A criticism of our data in MDYT1 subjects is that some of them were taking 
medication at the time of the study. Of the ten MDYT1 subjects, five were 
receiving medication at the time of the study. Two were receiving benzhexol, 
one clonazepam and benzhexol, one diazepam and one levodopa. It is likely 
that, if such medication has any effect at all on the parameters measured in 
our experiments, it would have the effect of redu cin g  cortical excitability, not 
causing the excessive cortical excitability revealed in our experiments. Our 
results in these medicated subjects did not differ systematically from those 
not taking medication, and our results overall fit in with established patterns 
of electrophysiological abnormality found in non-medicated patients with 
primary dystonia.
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Changes in non-manifesting carriers of the DYT1 mutation.
Clinically, movement control in the non-manifesting carriers of the mutation 
was indistinguishable from that of the normal controls. Despite this, 
electrophysiological tests revealed subclinical abnormalities: Two GABAergic 
circuits in the motor cortex were hypoexitable to the same extent as in 
manifesting individuals, as measured by ICI and SP. Spinal reciprocal 
inhibition appeared normal.
Previously, it has not been clear why NMDYT1 gene carriers do not manifest 
dystonia. One potential hypothesis is that the DYT1 gene has no physiological 
consequences in NMDYT1 individuals, perhaps through inactivation of the 
gene. Our results would indicate that this is not the case. Clinically non­
manifesting carriers of the DYT1 gene had clear electrophysiological 
abnormalities. In this respect, our data confirm those of Eidelberg et al 
(Eidelberg et al., 1998) who used PET to reveal subclinical metabolic 
abnormalities in the brains of non-manifesting individuals. However, our 
results also show that the abnormalities in NMDYT1 individuals are not as 
widespread as in MDYT1 patients.
It is interesting that the main abnormalities in NMDYT1 subjects lay in two 
cortical pathways known to be influenced by basal ganglia input: ICI and SP. 
This may indicate that the primary defect caused by the DYT1 gene is in basal 
ganglia function, and that this then leads to secondary changes in connected
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structures. Whatever the mechanism, the lack of clinical symptoms in 
NMDYT1 individuals suggests that there are other factors, perhaps not even 
tested in these experiments, which determine the expression of clinical 
dystonia. These factors could be at the level of the sensory system, which has 
been implicated in the genesis of dystonia, or possibly in the direct 
connections between the basal ganglia and the brainstem. Regardless of the 
nature of the additional abnormalities necessary for dystonia to develop, we 
suggest that genetic and/or environmental modifying factors are likely to play 
a part in determining the clinical phenotype. There has certainly been 
considerable debate about the role of environmental factors (particularly 
trauma) in triggering symptoms in primary dystonia. A recent report of 
monozygotic twins with familial adult-onset craniocervical dystonia suggested 
that trauma might have played a role in the greater severity of dystonia in 
one of the twins (Albanese et al., 2000). Epidemiological studies of patients 
with blepharospasm have implicated facial trauma as a risk factor for the 
development of the condition(Defazio et al., 1999). However, little is known 
about the role of such factors in the onset of dystonia in DYT1 gene carriers. 
A case-control study (published in abstract form only), implicated measles 
infection and high fever in early childhood as possible predisposing factors to 
the development of dystonia in DYT1 gene carriers (Sanders-Pullman et al, 
2000). Interestingly, torsin A, the protein product of the DYT1 gene, bears 
significant homology to heat shock proteins (Breakefield et al., 2001).
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The idea that electrophysiological abnormalities may exist without clinical 
signs of dystonia is not new. Subclinical abnormalities in the unaffected body 
parts of those with non-genetically characterised primary dystonia have been 
observed in previous electrophysiological studies. Examples of these 
abnormalities include abnormal reciprocal inhibition in the forearms of those 
with cervical dystonia(Deuschl et al., 1992), abnormal intracortical excitability 
in the hand motor area in those with blepharospasm (Sommer et al., 2002a) 
or in the unaffected arm of patients with writer's cramp (Ridding et al., 1995), 
and abnormal temporal discrimination of sensory inputs in the unaffected 
hand of those with writer's cramp (Fiorio et al., 2003). The implication is that 
additional abnormalities must occur to prompt appearance of symptoms. In 
such cases, additional reorganisation of central pathways produced by 
overuse or injury may be one trigger for dystonia. Thus in these dystonic 
conditions, as we suspect in DYT1 gene carriers, there also is an interplay 
between intrinsic and environmental modifying factors that modulates the 
clinical expression of underlying electrophysiological abnormalities.
In conclusion, we have shown that non-manifesting carriers of the DYT1 
gene, although they are clinically unaffected by dystonia, demonstrate some, 
but not all of the electrophysiological abnormalities found in DYT1 gene 
carriers with dystonia. This has two implications: first that the 
electrophysiological changes previously found in those with other forms of 
dystonia are not merely an artefact of dystonic movements themselves, as 
they can occur independently of clinical dystonia. Second, it implies that
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additional abnormalities are needed to cause clinical dystonia, perhaps in 
sensorimotor integration or basal ganglia-brainstem outflow. Our findings 
underline the importance of looking outside cortical motor abnormalities in 
dystonia to other aspects of the motor system for the clues to the genesis of 
dystonia in DYT1 gene carriers, and those with other forms of primary 
dystonia. In addition, it is also important to identify potential environmental 
and genetic modifying factors that could influence penetrance of the DYT1 
phenotype. If these could be identified, it is feasible that DYT1 gene carriers 
could be protected from, or at least counselled about, such factors. From a 
wider point of view such factors might give significant insights into the 
pathogenesis of primary dystonias, and have the potential to provide novel 
treatment strategies to correct these pathophysiological abnormalities.
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Chapter 6
An assessment of the effect of 1Hz rTMS on reciprocal inhibition in DYT1 
mutation carriers and normal subjects.
Introduction
This chapter presents details of an experiment designed as an initial 
exploration of the hypothesis that differential motor system plasticity might 
underlie the development of dystonia in DYT1 mutation carriers. As discussed 
above, there is a body of clinical, experimental and theoretical evidence that 
people with dystonia may be oversensitive to naturally occurring and 
experimental forces that produce synaptic plasticity. In this current study we 
set out to assess the ability of an experimental plastic force (1Hz rTMS) 
delivered over the premotor area to alter a measure of spinal motor inhibitory 
function: reciprocal inhibition (RI).
We chose 1Hz rTMS as our plastic force in this experiment. This type of low- 
frequency stimulation has been the most frequently used paradigm in human 
and animal studies to produce a long-term depressive (LTD) effect on the 
conditioned tissue. Previous studies in the human motor system have found 
this effect to be most marked when stimulation is given over the pre-motor, 
rather than the motor cortex. We hypothesised that an increase in RI might 
be seen in following rTMS. We expected this effect to be most marked in the
105
third phase of RI. Even though the exact nature of the third phase of RI is not 
known, its latency might suggest that it is a spino-bulbo-spinal or even a 
spino-cortico-spinal loop. As such it might be most susceptible to the effects 
of rTMS. We hypothesised that manifesting DYT1 carriers (MDYT1) might 
show the largest effect on RI from rTMS, with perhaps a lesser effect on non­
manifesting DYT1 carriers (NMDYT1), and a lesser effect still on normal 
subjects.
Results
All subjects completed the experiments and none reported any lasting side 
effects. Paired t tests showed that there was no change in size of the 
unconditioned H reflex before and after rTMS in control subjects (mean size 
before rTMS = 1.87mV; mean size after rTMS = 1.61mV; t=1.5, p=0.17) or 
DYT1 subjects (mean size before rTMS = 0.86; mean size after rTMS = 0.80; 
t=0.8, p=0.46).
Data for control, NMDYT1 and MDYTT subjects were grouped for analysis into 
the three phases of reciprocal inhibition (phase 1:0ms, phase 2:10-20ms and 
phase 3:75-500ms).
Figure 6.1 shows reciprocal inhibition for control subjects before and after 
rTMS, figure 6.2 shows data before and after rTMS for MDYT1 subjects, and 
figure 6.3 shows data before and after rTMS for NMDYT1 subjects.
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Figure 6.1: Reciprocal inhibition for control subjects before and after rTMS 
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Figure 6.2: Reciprocal inhibition for MDYT1 subjects before and after rTMS, 
with reciprocal inhibition before rTMS also shown for control subjects.
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Figure 6.3: Reciprocal inhibition for NMDYT1 subjects before and after rTMS, 
with reciprocal inhibition before rTMS also shown for control subjects.
Since the mechanisms of the 3 phases of reciprocal inhibition are thought to 
be different (the first phase is postsynaptic, the second phase presynaptic, 
and the third phase uncertain at the present time), a two way ANOVA was 
conducted separately on the data from each phase with TIME (before and 
after rTMS) and GROUP (controls/MDYTl/NMDYTl) as main factors. In the 
first phase there was a significant main effect of TIME (f(l,22)=4.73, 
p<0.05), but no effect of GROUP and no GROUP x TIME interaction. This was 
because there was a small but significant increase in the amount of inhibition 
during this phase after rTMS in MDYT1 subjects (paired t-test, p<0.05). In 
the second phase there was a significant main effect of GROUP (f(l,22)=5.96,
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p<0.05), due to reduced inhibition in MDYT1 subjects. However there was no 
main effect of TIME and no TIME x GROUP interaction, indicating that rTMS 
had no effect on this phase of RI in any group. Finally, in the third phase of 
inhibition there was a significant main effect of TIME (f(l, 22)=10.54, 
p<0.005) and a GROUP x TIME interaction (f(l,22)=11.53, p<0.005). Post 
hoc t tests (paired t test: p<0.005) indicated that this was due to the fact that 
rTMS increased the amount of RI in MDYT1 subjects but had no effect in 
controls or NMDYT1 subjects.
Discussion
We have demonstrated that reciprocal inhibition can be modified by 20 
minutes of 1-Hz rTMS given over the pre-motor area in subjects with dystonia 
due to the DYT1 mutation. In these subjects a significant normalisation of the 
third phase of reciprocal inhibition occurred after rTMS, so that MDYT1 
subjects were no longer significantly different in this phase compared to 
control subjects. The lack of change in the unconditioned H reflex following 
rTMS is compatible with the idea that there was no direct effect of the rTMS 
on excitatory spinal motoneurones. NMDYT1 and control subjects had normal 
reciprocal inhibtion pre rTMS, and did not show any change in inhibition 
following conditioning.
The first phase of reciprocal inhibition is due to activity in a disynaptic 
inhibitory pathway (Day et al., 1984) that was once thought to be analogous
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to the disynaptic la reciprocal inhibitory pathway described in the cat hindlimb 
(Hultborn, 1976). However, since it does not receive recurrent inhibition from 
forearm motoneurones, it has been suggested that evolution may have 
modified the connectivity of reciprocal inhibition to complement the increased 
circumduction movements that are possible at the human wrist (Aymard et 
al., 1995). The second phase of inhibition is thought to be due to presynaptic 
inhibition of the terminals of la afferents responsible for the H-reflex 
(Berardelli et al., 1987). The origin of the third phase is less clear. It has been 
proposed that it is due to continued presynaptic inhibition, and that the 
division between second and third phases is caused by superimposition of a 
short period of facilitation at around 50 ms (Berardelli et al., 1987). An 
alternative hypothesis is that, due to its long latency, it may involve long loop 
inhibitory connections from radial nerve to brainstem (spino-bulbo-spinal 
connections) or even cerebral cortex (transcortical connections) and thence 
back to the H-reflex pathway in the spinal cord.
Like many other spinal pathways, it is hypothesised that reciprocal inhibition 
in the forearm is influenced by descending inputs from supraspinal centres 
that control the excitability of the systems at rest and during movement (Day 
et al., 1984). Since there is no obvious pathology of the spinal cord in 
dystonia, reduced inhibition is thought to be due to changes in the level of 
tonic input from these supraspinal centres, but precisely which centres are 
affected in dystonia is unknown.
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Our data provide two pieces of information regarding these various 
hypotheses. First, rTMS in dystonic subjects had a differential effect on the 
second and third phases of reciprocal inhibition, supporting the hypothesis 
that they are indeed distinct phases with different underlying mechanisms. 
Second, our data confirm that the pathways that underlie reciprocal inhibition 
are influenced by changes in the activity of descending inputs. One could 
speculate that since the premotor cortex has extensive direct and indirect 
connections to the spinal cord, it may be able to influence the pathways 
underlying both the first and the third phases of reciprocal inhibition. 
Alternatively, if the third phase of RI is due to activity in a long-loop spinal- 
brainstem-spinal pathway then the effect on this phase may be due to 
changes in activity of premotor-brainstem connections. Via either of these 
mechanisms, an abnormality in premotor cortex activity may then contribute 
to the reduced third phase of inhibition in individuals with dystonia, and 
transient improvement after a period of rTMS may reflect a normalisation of 
this influence.
We chose to assess the motor hotspot in relationship to the FDI muscle rather 
than to muscles in the forearm that were involved specifically in the reciprocal 
inhibition pathway. We hypothesised that as the cortical motor representation 
of the FDI was so close to such muscles and given the broad field of 
stimulation provided by a standard TMS coil, that the FDI was a reasonable 
approximation to the forearm motor hotspot. It is, however, recognised that 
motor maps in dystonia may be distorted (Byrnes et al., 2005), and this may
i l l
therefore be a source of systematic difference between controls and DYT1 
subjects. However, the fact remains that DYT1 subjects showed a change in 
RI with rTMS which presumably must reflect the influence of such stimulation 
on inhibitory drive to the circuits underlying RI in the forearm.
Our data confirm physiologically Siebner et al's hypothesis (Siebner et al., 
2003) that the effects of rTMS at a distance from the site of stimulation may 
differ in patients and healthy subjects. Thus, stimulation of premotor cortex 
caused changes in reciprocal inhibitory pathways that were evident in patients 
but not controls. Although the mechanism behind this differential effect is 
unclear, it does appear that individuals with abnormal cortical excitability due 
to disease are more sensitive to the effects of rTMS.
With respect to NMDYT1 subjects, these data provide some limited evidence 
that the response to a "plastic force" such as rTMS may differ between 
manifesting and non-manifesting DYT1 subjects. Both groups are known to 
have abnormal cortical inhibitory function (as assessed by SICI and SP), but 
at baseline reciprocal inhibition is only abnormal in MDYT1 subjects. Following 
conditioning there was a clear change in reciprocal inhibition in MDYT1 
subjects, but no such change was seen in NMDYT1 subjects. This may be due 
to differential effects of rTMS in manifesting and non-manifesting subjects 
(with manifesting subjects being more "sensitive" to a plastic force than non- 
manifesters). However, due to a floor effect, it may be that it is simply not 
possible to alter the normal reciprocal inhibition seen in NMDYT1 subjects.
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This study therefore provides some preliminary evidence that there may be a 
differential sensitivity to the effects of rTMS in manifesting and non­
manifesting DYT1 carriers.
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Chapter 7
A comparison of motor system plasticity in manifesting and non­
manifesting DYT1 carriers, subjects with adult-onset dystonia and 
controls.
Introduction
The last chapter presented details of an experiment using rTMS as an 
experimental "plastic force" in DYT1 mutation carriers. In this experiment we 
used a test of spinal motor inhibitory function (spinal reciprocal inhibition: RI) 
to assess the response of subjects to rTMS. We found a significant 
normalisation of RI in MDYT1 subjects, but no change in NMDYT1 or controls.
These results could be interpreted as suggesting that response to rTMS is 
excessive in MDYT1 subjects compared to NMDYT1 and normal controls as 
they are the only subject group to demonstrate a change in RI following 
conditioning. One could conclude that excessive synaptic plasticity is therefore 
a primary abnormality in those who manifest dystonia. However, there are a 
number of confounding factors that might affect this conclusion. Firstly,
MDYT1 subjects were to only group to have abnormal RI at baseline. One 
could argue that because RI is abnormal, it might be easier to change it with 
an intervention such as rTMS, compared with the situation where it is normal 
as in NMDYT1 and controls. Secondly, it is possible that an excessive
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response to a plastic force such as rTMS occurs as a consequence of dystonic 
movements being present for a number of years; i.e. the abnormal response 
to rTMS is a secondary phenomenon, and not indicative of a primary driving 
force behind the development of dystonia.
We therefore wished to assess synaptic plasticity in the motor system in a 
different way, not so open to these confounding factors. We therefore chose 
to assess change in MEP size following rTMS in our subjects. Motor thresholds 
are not different in those with dystonia compared to normal subjects. As 
described in chapter 3 we found abnormalities in cortical inhibition that were 
similar in severity between MDYT1 and NMDYT1 subjects.
Results
No side effects were observed or reported by any subject following rTMS. All 
subjects completed the experiment.
As expected, we found that normal subjects had a significant decrease in MEP 
size following rTMS which lasted for approximately 20 minutes (fig. 1). In 
contrast, manifesting DYT1 subjects had a significantly prolonged response to 
rTMS, with MEP size still maximally suppressed at the end of assessment (fig. 
1).
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Figure 7.1:Normalised MEP size at baseline and following rTMS in normal 
subjects and manifesting DYT1 mutation carriers (MDYT1). 2 way ANOVA 
revealed a significant TIMEx GROUP interaction (F(7/84)=2.99/ p<0.01). Post 
hoc analysis revealed this to be due to a significantly prolonged suppression 
of MEP size after 20 minutes in MDYT1 subjects compared to controls 
(p<0.01). Error bars indicate standard error.
A similar pattern was observed in subjects with sporadic, adult-onset 
dystonia, who also had a significantly prolonged suppression of MEP size 
following rTMS (fig. 7.2).
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Figure 7.2: Normalised MEP size at baseline and following rTMS in normal 
subjects and subjects with aduit-onset neck dystonia (torticollis). 2 way 
ANOVA revealed a significant TIMEx GROUP interaction (F(7/77)=3.84/ 
p<0.001). Post hoc analysis revealed this to be due to a significantly 
prolonged suppression of MEP size after 20 minutes in torticollis subjects 
compared to controls (p<0.01). Error bars indicate standard error.
Non-manifesting DYT1 subjects were also abnormal in the their response to 
rTMS, but in the opposite direction, showing no significant change in MEP size 
at any time point after rTMS, significantly different in this respect from both 
normal and dystonia subjects (fig. 7.3).
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Figure 7.3: Normalised MEP size before and after rTMS in normal subjects and 
non-manifesting DYT1 mutation carriers. 2 way ANOVA revealed a significant 
TIMEx GROUP interaction (F(7/77)=2.22/ p<0.05). Post hoc analysis revealed 
this to be due to significantly reduced MEP suppression in NMDYT1 subjects 
compared to controls. Error bars indicate standard error of the mean.
Discussion
We have demonstrated that an abnormal response to an experimental plastic 
force occurs in individuals who are genetically susceptible to dystonia, and 
that the direction of the abnormal response is determined by the presence or 
absence of clinical symptoms. Thus in DYT1 mutation carriers with dystonia
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(and also in sporadic adult-onset dystonia) the response to induction of plastic 
change in the motor cortex is excessive. One could argue that this abnormal 
response occurs secondary to changes in the motor system caused by long­
standing dystonia. However, the presence of a s ^ n o rm a l response to the 
attempted induction of plastic change in the motor cortex in non-manifesting 
DYT1 subjects suggests a primary role for brain plasticity in the development 
of clinical dystonia. The subnormal responsiveness of the system underlying 
plastic change in the brain observed in non-manifesting DYT1 carriers may 
have implications for other brain functions that require plastic changes to 
occur, and in this regard it is interesting that a deficit in the ability to perform 
a motor sequence learning task has been reported in non-manifesting DYT1 
mutation carriers (Ghilardi e t al., 2003).
It would be of considerable importance to determine which aspect(s) of the 
complex system that regulates brain plasticity determines the differential 
response to rTMS observed in DYT1 mutation carriers. In experimental 
models of plasticity, modulation of GABA (Chen et al., 1994) and dopamine 
(Kusuki et al., 1997) can alter the direction of plastic change (LTP vs. LTD) in 
response to a particular pattern of stimulation. GABA would appear to be an 
unlikely candidate to explain the difference in motor cortex plasticity in DYT1 
mutation carriers, as electrophysiological tests designed to probe the function 
of GABA in the motor system are similarly impaired in manifesting and non­
manifesting carriers (see chapter 5). Dopamine may prove to be a more 
promising contender. Although there is no loss of dopaminergic cells in DYT1
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dystonia, torsin A is known to be maximally expressed in dopaminergic 
neurons (Augood et al., 1999; Konakova et al., 2001) and has been linked to 
the function of VMAT2, a protein controlling the quantal release of dopamine 
at the synapse (Misbahuddin et al., 2005). Dopamine turnover in the brains of 
those with manifesting DYT1 dystonia may be increased (Augood et al.,
2002), and recently, abnormalities in post synaptic dopamine receptors have 
been found in DYT1 carriers (Asanuma et al., 2005). Increased concentrations 
of dopamine promote LTP, and one might speculate that in manifesting DYT1 
carriers, abnormal (excessive) dopamine release in response to natural stimuli 
that can promote plastic changes in the motor cortex, produce an excessive 
response. This could lead to excessive excitability of motor pathways, and 
therefore loss of the normal pattern of centre-surround inhibition that 
characterises normal motor system operation. In non-manifesting DYT1 
carriers, one would have to hypothesise a compensatory mechanism that 
mitigates this deficit, perhaps mediated by another genetic factor. Future 
studies to identify the mechanism of differential plasticity in DYT1 carriers 
could determine potential therapeutic targets capable of being exploited to 
modulate the emergence of clinical dystonia in susceptible individuals.
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CHAPTER 8
Conclusions
Individuals who carry the DYT1 gene mutation have a 30-40% chance of 
developing dystonia, and do so in an age-dependent fashion (Bressman et al.,
2000). The unique model provided by this natural occurrence has allowed us 
to identify those aspects of motor system dysfunction are may be 
fundamental to the production of clinical dystonia, and which aspects may be 
protective against the development of symptoms in genetically susceptible 
individuals.
We have shown that abnormalities in cortical motor inhibition can be present 
to the same severity in manifesting and non-manifesting carriers of the DYT1 
mutation, demonstrating that they are not sufficient on their own to cause 
dystonia to manifest. We developed a new hypothesis regarding the 
manifestation of symptoms in DYT1 mutation carriers based on abnormalities 
in synaptic plasticity in the motor system. We demonstrated excessive 
synaptic plasticity in manifesting mutation carriers, but sub-normal plasticity 
in non-manifesting carriers. These data place abnormalities in the sensitivity 
of the "synaptic plasticity system" at the heart of a model to explain the 
pathogenesis of DYT1 dystonia, and by inference, primary dystonia in general.
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The next key step in the understanding of dystonia pathophysiology would be 
to identify which part(s) of the complex mechanism controlling the sensitivity 
of synaptic plasticity drives the different response of manifesting and non­
manifesting carriers to rTMS. This aspect might well provide a pathway 
towards the ability to manipulate, for therapeutic gain, synaptic plasticity in 
manifesting carriers, perhaps even at a pre-symptomatic stage. It might also 
be of use to those with commoner forms of primary dystonia in whom a 
related mechanism may be responsible.
It seems likely that any therapeutic intervention that does not take account of 
abnormal synaptic plasticity in people with dystonia is likely to fail in the long 
term. Thus, although benefit has been reported from re-training methods in 
dystonia patients (Cabrera-Lopez et al., 2003; Candia et al., 1999; Candia et 
al., 2002; Zeuner et al., 2002), it seems likely that the underlying tendency 
towards excessive plastic changes will undo any benefit from such retraining 
techniques. This seems particularly likely in those who are re-exposed to the 
same stimulus that originally triggered the dystonia such as professional 
musicians. Such people might benefit from re-training coupled with a method 
to prevent excessive plastic changes happening once retraining has finished.
rTMS is one method of experimentally inducing plastic change. Traditional 
methods of rTMS have some disadvantages as a therapeutic intervention: 
they are slow to produce changes, changes are subject to inter and intra 
individual variation (Sommer et al., 2002b), and technical problems (e.g. high
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resting threshold) can interfere with conditioning. The technique of theta 
burst stimulation (Appendix 1) offers a faster and more consistent method of 
inducing plastic change using rTMS, and may therefore be more suitable as a 
therapeutic tool.
It is possible that rTMS, or other methods of experimentally inducing plastic 
change such as IPAS can be combined with re-training to produce long lasting 
"remapping" of distorted motor maps in dystonia, and therefore lasting clinical 
benefit.
This study has shown that synaptic plasticity can be both a protective and a 
damaging force. The task ahead is to understand how this system can be 
controlled, and its great powers harnessed for the benefit of those with 
dystonia.
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APPENDIX 1: Details of a novel paradigm of rTMS in humans: Theta 
Burst Stimulation.
Published as: Huang Y-Z, Edwards MJ, Rounis E, Bhatia KP, RothwelIJC.
Theta Burst Stimulation of the Human Motor Cortex. Neuron 2005;45:201- 
206.
Introduction
In animal experiments it has long been possible to probe and manipulate the 
efficacy of synaptic transmission by repetitive electrical stimulation of central 
nervous pathways. This leads to the well-studied phenomena of long term 
potentiation (LTP) and depression (LTD) of synaptic connections. Repetitive 
transcranial magnetic stimulation (rTMS), which is a non-invasive method of 
stimulating the brain of conscious human subjects through the intact scalp, 
has obvious potential for mimicking the effects that have been observed in 
animal models. Yet despite the striking effects on synaptic transmission that 
have been achieved in animals, translation to the human brain using rTMS 
has been relatively disappointing.
Investigations have been carried out on three levels: physiological, 
behavioural and clinical. All are designed to detect changes in function that 
outlast the application of particular patterns of rTMS to selected areas of 
cortex. The majority of physiological studies have employed the motor cortex 
since it is possible to use the size of the electromyographic (EMG) response to
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a single TMS pulse as an objective measure of cortical excitability. Here, 
results are often weak, highly variable from one individual to another (Maeda 
et al., 2000a), and rarely last longer than half an hour. Behaviourally, the 
experiments on the motor system produce no obvious effects on basic motor 
parameters such as strength or speed of contraction (Muellbacher et al.,
2000). However, small changes can be seen in more complex paradigms. 
Similarly, rTMS over other cortical areas can induce subtle changes in 
cognitive functions (Evers e t al., 2001; Hadland et al., 2001; Sparing et al.,
2001), but again these are relatively modest. Clinically, rTMS has been used 
to try to treat a variety of neurological and psychiatric conditions from 
Parkinson's disease to obsessive compulsive disorder. The largest number of 
trials has been for depression, but again, the results have been equivocal 
(Hausmann et al., 2004; Martin et al., 2003).
There are several possible reasons for the previous disappointing results of 
rTMS: first, even in animal experiments, LTP/LTD is difficult to demonstrate in 
the cortex of awake and freely moving animals without the use of extended or 
repeated sessions of stimulation (Froc et al., 2000; Trepel and Racine, 1998). 
Second, concerns over safety have limited many humans studies to relatively 
low frequencies of stimulation (usually <10 Hz) (Wassermann, 1998) whereas 
animal studies often use much higher frequencies such as the "theta burst" 
paradigm (3-5 pulses at 100 Hz repeated at 5 Hz) (Hess et al., 1996; 
Huemmeke et al., 2002; Larson and Lynch, 1986; Vickery et al., 1997). Third,
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TMS in humans is relatively non-focal, and therefore cannot be used to target 
spatially specific neural connections. In most instances, this means that rTMS 
will activate a mixture of systems that potentially could have interacting 
effects that make the final outcome difficult to predict.
Other stimulation methods have been used to try to induce plastic changes in 
human cortex, for example paired associative stimulation (PAS) (Ridding and 
Uy, 2003; Stefan et al., 2000), or transcranial direct current stimulation 
(Nitsche and Paulus, 2000). PAS can produce controllable change in cortical 
excitability, but protocols typically require periods of conditioning of around 
30 minutes, and peripheral stimulation is given at 2-3 times sensory threshold 
which may be uncomfortable for some subjects. There is less experience with 
the use of tDCS, and again conditioning times of over several minutes 
typically are needed to produce any effect.
A recent pilot study has shown that a single short, low intensity burst of rTMS 
at 50 Hz is safe and can target specific populations of neurones in the motor 
cortex (Huang and Rothwell, 2004). In the present experiments we have 
aimed to produce clear after effects of rTMS in the human motor cortex, by 
employing repeated application of such bursts in modified "theta burst" 
paradigms (TBS).
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Experimental Procedures
Subjects
Subjects were nine healthy volunteers between the ages of 23 and 52 (mean 
age: 33.6±7.8 years) who gave their informed consent for the experiments. 
The project protocol was approved by the Joint Ethics Committee of the 
National Hospital for Neurology and Neurosurgery.
Stimulation and Recording
Subjects were seated and EMGs recorded with a gain of 1000 and 5000 using 
Ag-AgCI surface electrodes over the right first dorsal interosseous muscle 
(dominant hand in all subjects). Magnetic stimulation was given over the hand 
area of the motor cortex using a hand-held figure of eight coil (70 mm 
standard coil, Magstim Co., Whitland, Dyfed, UK) placed tangentially to the 
scalp with the handle pointing posteriorly. Single and paired pulses were 
delivered by Magstim 200 machines, and rTMS was delivered using a Magstim 
Super Rapid stimulator. The stimulation intensity was defined in relation to 
the active motor threshold (AMT) for each Magstim machine separately as the 
minimum single pulse intensity required to produce an MEP of greater than 
200^iV on more than five out of ten trials from the contralateral FDI while the 
subject was maintaining a voluntary contraction of about 20% of maximum 
using visual feedback.
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Experiments
The patterns of rTMS all consisted of bursts containing 3 pulses at 50Hz and 
an intensity of 80% AMT repeated at 200ms intervals (i.e. at 5Hz). In the 
intermittent theta burst stimulation pattern (iTBS), a 2s train of TBS is 
repeated every 10s for a total of 190s (600 pulses). In the intermediate theta 
burst stimulation paradigm (imTBS) a 5s train of TBS is repeated every 15s 
for a total of 110s (600 pulses). In the continuous theta burst stimulation 
paradigm (cTBS) a 40s train of uninterrupted TBS is given (600 pulses). (Fig. 
1A) An additional comparison was made in some subjects with regular 15Hz 
stimulation at the same intensity.
Corticospinal excitability was assessed by measuring the peak-to-peak 
amplitude of MEPs in the contralateral FDI muscle to single pulse TMS in 
resting subjects. Before TBS 30 pulses were given every 4.5-5.5s. After TBS, 
batches of MEPs to 12 single pulses were measured at different intervals.
To better understand the mechanism of our different TBS paradigms, we 
explored the effect of a single train of 10 and 25 bursts given over the motor 
hand area. MEPs were accessed 4-5 seconds before the train of bursts and at 
1 second, 5 seconds, 10 seconds, and 15 seconds after the train in one block 
of testing. The block was then repeated every 40-45 seconds for 10 repeats. 
Two separate sessions using either a 10 bursts or a 25 burst train were
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assessed in each subject. Five subjects (3 men, 2 women; mean age, 27±5 
years) were recruited in this part.
We assessed short interval intracortical inhibition (SICI) and facilitation 
(ICF) in the motor hand area of seven subjects before and after TBS using the 
double-pulse method described by Kujirai et al (Kujirai et al., 1993). SICI was 
evaluated at an interstimulus interval (ISI) of 2ms using a conditioning 
intensity of 80% AMT, and ICF at an ISI of 10ms with a conditioning intensity 
of 90% AMT. Two blocks of baseline SICI and ICF were recorded with 10 
trials of each condition randomly intermixed with controls. The RMT was 
increased from 49.0±8.9% to 51.0±9.7% of maximum output of the magnetic 
stimulator (t=-3.24, p<0.05) by cTBS, while AMT stayed unchanged (t=0.55, 
ns). We therefore adjusted the intensity of the test stimuli while assessing 
SICI and ICF after TBS to maintain the amplitude of test MEPs at 
approximately 1 mV, but left the conditioning intensity unchanged.
We also tested the H-reflex and MEP in the contralateral flexor carpi radialis 
(FCR) muscle before and after cTBS on seven subjects. One block mixing 12 
trials of H-reflex and 12 trials of MEP was recorded prior to conditioning, and 
another block was recorded at 10 min after cTBS.
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In a separate experiment, we assessed reaction time before and after cTBS in 
nine subjects. Subjects were seated in a comfortable chair with each index 
finger placed on a button. An electrical stimulus at an intensity of 3 times 
sensory threshold was delivered randomly to the left or the right hand 
through Ag/Ag-Ci electrodes attached over the hypothenar eminence.
Subjects were instructed that when they felt a stimulus on the right or the left 
hand, that they were to press the button under the corresponding finger as 
quickly as possible. In addition, subjects were asked to press the button with 
a particular force (approximately 2.5 N) with respect to visual feedback given 
on a screen in front of them.
Two blocks of reaction time testing were performed, with 40 stimuli to each 
hand given at random intervals, ranging from 1.5 to 2.5 seconds, and in a 
random pattern. cTBS was then given over the left motor hand area, and the 
process repeated at 10 and 30 min.
Data analysis
Data were analysed using SPSS for Windows version 11.0. Repeated 
measures ANOVA was used to compare variables before and after TBS, and 
paired t-tests were used to compare the effect of TBS on H-reflexes and MEPs 
recorded from FCR and the effect of a single pulse. Statistics for the data in 
Fig. 1 comparing the effect of iTBS, imTBS and cTBS were performed on
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normalised data, whereas the statistical analysis of each time course 
separately was performed on absolute values. The comparison of data 
between MEP and H reflex was performed on log transformed values in order 
to normalise the distribution of the amplitude data. All figures represent group 
data. Error bars refer to the standard error of the measurements.
Results and Discussion
In the first experiment three patterns of TBS (Fig. 1A), each consisting of a 
total of 600 pulses at an intensity of 80% active motor threshold were given 
on different days to the primary motor cortex of same group of subjects. The 
basic element of all of these patterns was a burst of 3 stimuli at 50 Hz (i.e. 
20ms between each stimulus) which was repeated at intervals of 200ms (i.e.
5 Hz). We refer to these patterns as continuous TBS (cTBS), intermittent TBS 
(iTBS) and intermediate TBS (imTBS). The excitability of the corticospinal 
system before and after TBS was measured using single pulse TMS to evoke 
EMG responses (motor evoked potentials, MEPs) in a small hand muscle. Fig. 
IB shows that after cTBS MEPs were suppressed for over 20 min, whereas 
they were unaffected after imTBS and facilitated after iTBS (ANOVA: 
significant effect of PATTERN (i.e. iTBS, imTBS, or cTBS) (f(2,16) =20.32 , p 
<0.001) with significant post hoc differences between each pair of TBS 
patterns). Fig. 1C shows that the duration of the after effects was shorter 
when fewer TMS pulses were applied in the cTBS pattern. MEPs were 
suppressed for 60 min after a total of 600 pulses (i.e. 40s cTBS) whereas they
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were suppressed for only 20 min after 300 pulses (i.e. 20s cTBS) (ANOVA: 
significant TIME x DURATION interaction (f(14,112)=2.24, p<0.05). In a 
subset of 6 subjects we extended the period of measurement beyond 60 min 
in order to confirm that the effects of 40s cTBS had returned to baseline after 
1 hour (Fig ID). The one way ANOVA on this data revealed a significant effect 
to TIME (f(3,15)=4.36, p<0.05), with post hoc tests showing significant 
suppression of MEPs at 25 and 45 min but not at 61 and 65 min.
In order to understand which features of TBS patterns are critical to the 
observed after effects, we compared the results of applying 300 TMS pulses 
continuously at 15 Hz with the same number of pulses in the cTBS pattern. 
Although it took 20s to apply each type of conditioning, only the cTBS pattern 
had any after effect on the responses to TMS (Fig. IE) (significant interaction 
between TIME and PATTERN (f(14,84)=2.55, p<0.005), confirming the 
importance of the high frequency burst component of TBS for producing long- 
lasting after effects.
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Figure 1 A-E: Paradigms of TBS and their effects on MEPs. Fig. 1A gives a 
graphical illustration of the three stimulation paradigms used. Each paradigm 
uses a theta burst stimulation pattern (TBS) in which 3 pulses of stimulation 
are given at 50Hz, repeated every 200ms. In the intermittent theta burst 
stimulation pattern (iTBS), a 2s train of TBS is repeated every 10s for a total 
of 190s (600 pulses). In the intermediate theta burst stimulation paradigm 
(imTBS) a 5s train of TBS is repeated every 15s for a total of 110s (600 
pulses). In the continuous theta burst stimulation paradigm (cTBS) a 40s train 
of uninterrupted TBS is given (600 pulses). Fig. IB shows the time course of 
changes in MEP amplitude following conditioning with iTBS (A ), cTBS ( f ), or 
imTBS (o). There was a significant effect of pattern of stimulation on change 
in MEP size following stimulation (f(2,16)=20.32, p<0.001), with significant 
post hoc differences between each pattern of stimulation. There was a
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significant facilitation of MEP size following iTBS lasting for about 15 mins, 
and a significant reduction of MEP size following cTBS lasting for nearly 60 
mins. im TBS produced no significant changes in MEP size. Fig. 1C compares 
the effects ofcTBS given for 20s (300pulses; CTBS300 (o)) with the same 
paradigm given for 40s (600pulses; cTBS600(W)). There was a significant 
effect of duration ofcTBS conditioning on the time course of the effect 
(significant TIMExDURATIONinteraction (f(14/112)=2.24/ p<0.05)) with the 
effect of CTBS300 lasting about 20 minutes compared to the effect of 
CTBS600 which lasted about 60 minutes. Fig 1 D shows the effects of 
CTBS600 on a longer time scale in order to confirm the return to baseline 
levels after 1 hour. Data are from 6 subjects and show suppression at 25 and 
45 min but no effect at 61 and 65 min. Fig. IE compares the effect of 
continuous 15Hz stimulation for 20s (o) (300 pulses) with cTBS given for 20s 
(o) (300pulses). Only the cTBS paradigm had any effect on MEP size 
following stimulation, and there was a significant interaction between TIME 
and PA TTERN (f(14,84)=2.55, p<0.005). This graph also shows more clearly 
than Fig. 1C that the effect of CTBS300 had returned to baseline by 20 min.
A second experiment compared the effect of applying a single train of TBS for 
either 2s (i.e. the individual component of the iTBS pattern) or 5s (the 
component of the imTBS pattern). Fig. 2A shows that as expected from the 
small total number of pulses applied, these short trains produced after effects 
that lasted only 15s or so. However, a 2s train had a purely facilitatory effect 
on MEPs (Fig. 2A), whereas MEPs were initially facilitated after a 5s train, but
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then suppressed at 10s before returning to baseline at 15s (Fig. 2B). Given 
that a 20s train of TBS (i.e. the cTBS pattern) is purely suppressive, this 
suggests that a single train of TBS can lead to a mixture of suppressive and 
facilitatory effects on MEPs, with facilitation building up faster than 
suppression, but with suppression being more powerful in the long term.
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Figure 2A and 2B: The effect on MEP size of a short burst of TBS. MEP size 
was measured at baseline and then at 1, 5f 10 and 15s following the end of 
stimulation. Following a 2s train of TBS (Fig. 2A) there was a significant 
facilitation of MEP size (f(4/16)=6.99/ p<0.005). In contrast a 5s train of TBS 
(Fig.2B) produced an initial significant facilitation of MEP size at 1 second
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after the end of stimulation (p<0.05) followed by a significant suppression of 
MEP size at 10s (p<0.05).
Given the very low intensity of the individual pulses used in the conditioning 
trains (80% AMT), it is unlikely that TBS produced any activity in descending 
corticospinal fibres, and therefore that there were any direct effects of TBS on 
the excitability of circuits in the spinal cord that could contribute to the MEP 
changes that were observed. Consistent with this, we found that cTBS with 
300 pulses had no effect on H reflexes evoked in forearm flexor muscles 
whereas MEPs were suppressed (ANOVA on log transformed amplitude data 
of H-reflex and MEP: significant interaction between TIME and RESPONSE 
TYPE (f(l,7)=6.05, p<0.05).
To confirm that TBS has an effect on the excitability of circuits intrinsic to the 
motor cortex, we measured short interval intracortical inhibition (SICI) and 
intracortical facilitation (ICF) before and after iTBS and CTBS300 using a 
paired pulse paradigm. In these experiments, the intensity of the second, 
test, stimulus was adjusted so that it evoked the same size of baseline MEP 
before and after TBS. Fig. 3A, B shows that SICI was significantly facilitated 
following iTBS (ANOVA on the time course: f(4,24)=5.01, p<0.005) and 
suppressed after cTBS (f(5,30)=3.75, p<0.01). In contrast, ICF was
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unaffected by iTBS and slightly reduced 10 minutes after CTBS300 
(f(2,12)=7.40, p<0.01) (Fig. 3C, D).
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Figure 3 A-D: The effect of iTBS and cTBS on short intracortical inhibition 
(SICI) and facilitation (ICF). (A) SICI was significantly increased following 
iTBS (f(4/24)=5.01/ p<0.005), but (B) was reduced following cTBS 
(f(5,30)=3.75, p<0.01). (C) ICF was not significantly altered following iTBS, 
but (D) was significantly reduced at 10 mins following cTBS (f(2,12)=7.40,
p<0.01).
Unlike most other methods of conditioning the motor cortex (Chen et al., 
1997; Muellbacher et al., 2000), cTBS with 300 pulses in total produced clear
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changes in simple reaction times. In this experiment, CTBS300 was applied to 
the left motor cortex and reaction times measured in the right (conditioned) 
and left (unconditioned) hands (Fig. 4). A two factor ANOVA revealed a 
significant interaction between time (before and after CTBS300) and hand 
(f(2,16)=4.30, p<0.05.) indicating that CTBS300 had a different effect on the 
reaction times of the two hands. One factor analyses showed that there was a 
significant effect of time in both hands (conditioned hand: f(2,16)=12.77, 
p<0.001; unconditioned hand: f(2,16)=7.82, p<0.005) However, in the 
unconditioned hand this was due to a decrease in reaction times 30 min after 
CTBS300, whereas in the conditioned hand it was due to an increase in 
reaction time 10 min after CTBS300. The accuracy of the force with which 
subjects pressed the button was not changed in either hand following 
conditioning (conditioned hand: (f(2,16)=0.18, ns; unconditioned hand: 
f(2,16)=1.14, ns)
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Figure 4A and 4B: Fig. 4 illustrates the changes in simple reaction time 
following cTBS. There was a significant lengthening of reaction time in the 
conditioned hand 10 min after cTBS (f(2/16)=4.30/ p<0.05; Fig.4A), and a
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significant shortening of reaction time in the unconditioned hand 30 min after 
cTBS(f(2/16)=7.82/ p<0.005; Fig. 4B).
These data confirm that very short periods of low intensity TBS over motor 
cortex can have powerful effects on physiology and behaviour that outlast the 
conditioning by up to 1 hour. Since spinal H-reflexes were unaffected whereas 
two sets of intracortical circuitry tested by SICI (a probably GABAa-ergic 
pathway (Chen et al., 1998; Hanajima et al., 1998; Reis et al., 2002; Ziemann 
et al., 1998)) and ICF (pathway unknown) were clearly modulated, it seems 
likely that TBS was exerting its main effects on the excitability of neurones in 
the motor cortex. Given that there is now good evidence that other forms of 
TMS conditioning produce their after effects by changing the effectiveness of 
synaptic interactions (Lee et al., 2003; Siebner et al., 2003; Siebner et al., 
2000), we believe that the present results are compatible with induction of 
similar mechanisms.
At first sight the opposite effects of different patterns of TBS are surprising. 
However, a similar dissociation has been noted in previous work on animal 
preparations: patterns of intermittent TBS similar to our iTBS paradigm are 
routinely used to facilitate synaptic connections(Capocchi et al., 1992; Hess 
and Donoghue, 1996; Heynen and Bear, 2001), whereas a small number of 
studies have used longer trains of TBS-like paradigm to produce suppression
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(Heusler e t al., 2000; Takita e t al., 1999). Our data would be compatible with 
similar mechanisms in which cTBS might reduce the efficacy of transmission 
through the synaptic connections that are recruited when evoking an MEP 
(i.e. the I wave circuits) whereas iTBS would have the opposite effect. Similar 
arguments can account for the changes in SICI and ICF that we observed. 
Thus, we suggest that cTBS decreased the effectiveness of synaptic 
connections that are recruited in circuits involved in both SICI and ICF. This 
would reduce SICI, resulting in less MEP inhibition probed by SICI, and also 
reduce MEP facilitation probed with ICF. Conversely, iTBS, which facilitated 
MEPs might also increase the effectiveness of connections involved in SICI 
and increase MEP suppression probed by SICI. There was no corresponding 
facilitation of the SICF circuit in the present data after iTBS. The reason for 
this is unclear, but it may be related to the fact that more than one circuit 
contributes to ICF (Hanajima et al., 1998), or that we simply did not have 
sufficient subjects to demonstrate statistically significant facilitation. If so, 
then a simplified conclusion would be that cTBS had an inhibitory effect on 
the circuits underlying MEP production (I wave circuits), SICI and ICF, while 
iTBS had an opposite effect on these circuits.
We found our different TBS paradigms to have large effect sizes and 
acceptable inter-individual variability compared with traditional rTMS 
paradigms. Thus, the mean percentage change of MEP size in the period 
where the maximum effect occurred (i.e. 7-14 min after CTBS300,15-40 min
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after CTBS600, 1-10 min after iTBS) was -45.0% (SD= 8.9%), -42.2%  
(SD=24.0%) and 75.7% (SD=40.9%), respectively. These effect sizes and 
variability compare well with traditional rTMS paradigms, such as those 
explored by Maeda et al (2000), where a much larger number of rTMS pulses 
(1600) produced mean effects o f -34.03%  (SD=37.87%) after 1Hz and 
37.87% (SD=53.59%) after 10Hz.
The effectiveness of these paradigms raises ethical issues about the use of 
these methods in normal human subjects, who have nothing to gain from 
modulation of synaptic plasticity, in contrast to patients with particular 
neurological disorders. We were aware of these ethical issues, and as well as 
putting our proposed experimental methods before the ethics committee of 
our institution and gaining consent from subjects, we pursued the 
experiments in an incremental fashion starting with smaller intensities and 
lower frequencies of stimulation than those reported here. We found in all 
experiments that cortical excitability eventually returned to baseline, and no 
subjects reported any side effects from experimentation. However, as 
methods for inducing plastic changes in human cortex become more 
powerful, such issues will require constant scrutiny and vigilance on the part 
of experimenters.
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The results of the experiments with single trains of TBS suggest that in 
humans TBS produces a mixture of facilitatory and inhibitory effects on 
synaptic transmission, with facilitation building up faster than inhibition. If we 
assume that both facilitation and inhibition saturate at some level, then it is 
possible to explain the main features of the results as long as we allow 
inhibition to dominate in the long run. Thus, a short, intermittent protocol 
such as iTBS would favour rapid build up of facilitation. In contrast, a longer 
lasting continuous protocol such as cTBS would initially produce facilitation, 
but evenetually this would saturate and inhibitory effects which build up 
slower, but saturate at a higher level would dominate. An intermediate 
protocol such as imTBS might have no net effect by achieving a balance 
between the build up of inhibitory and facilitatory effects. This model is 
speculative at this stage, but would be consistent with several studies in 
animal preparations in which a mixture of opposing effects on LTP and LTD 
has been induced by the same protocol. For example, blocking some of the 
pathways that are needed for LTD induction, e.g. inositol triphosphate 
receptors (Nishiyama et al., 2000), can result in LTP after a protocol that 
usually produces LTD, whereas blocking LTP-dependent receptors, e.g. NMDA 
subunit 2A (Liu et al., 2004), may convert LTP into LTD. In addition, it has 
been shown that on occasion, a single protocol can cause LTP in some 
neurons whereas it results in LTD in others (Barbosa et al., 1990; Blackstone 
et al., 2003).
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In conclusion, we have developed novel methods of delivering rTMS based on 
patterns of theta burst stimulation. We have found these stimulation 
paradigms to be safe in normal subjects, and capable of producing consistent, 
rapid and controllable electrophysiological and behavioural changes in the 
function of the human motor system that outlast the period of stimulation by 
over 60 minutes. In particular we have found that the pattern of delivery of 
TBS (continuous versus intermittent) is crucial in determining the direction of 
change in synaptic efficiency. The method may prove useful not only in the 
motor cortex but also in other regions of the brain for both the study of 
normal human physiology and for therapeutic manipulation of brain plasticity.
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